{"2021-11-30": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Asian FX, stocks pare gains on Moderna CEO's Omicron warning - Reuters", "description": "Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean shares dropped over 2% on weak domestic data.", "url": "https://www.reuters.com/markets/stocks/asian-fx-stocks-pare-gains-moderna-ceos-omicron-warning-2021-11-30/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-11-30T08:02:00Z", "content": "Nov 30(Reuters) - Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean \u2026 [+2829 chars]"}], "2021-12-10": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Tesla, Southwest Airlines, Snap Inc, Moderna, SM Energy - Reuters", "description": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive tightening of its monetary policy.", "url": "https://www.reuters.com/markets/asia/tesla-southwest-airlines-snap-inc-moderna-sm-energy-2021-12-10/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=63", "publishedAt": "2021-12-10T15:55:00Z", "content": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive\u2026 [+2796 chars]"}], "2021-12-02": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Moderna may have Omicron booster by March | Reuters Video - Reuters.com", "description": "Moderna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Katayama reports.", "url": "https://www.reuters.com/video/watch/idOVF6COH3F", "urlToImage": "https://static.reuters.com/resources/r/?d=20211202&i=OVF6COH3F&r=OVF6COH3F&t=2", "publishedAt": "2021-12-02T16:54:12Z", "content": "Posted \r\nModerna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Kat\u2026 [+13 chars]"}], "2021-12-17": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "CDC panel recommends Pfizer, Moderna over J&J shot - Reuters", "description": "A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal case\u2026", "url": "https://www.reuters.com/video/watch/idPBOo?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bbd0a4e4b09631b0e445ba-1639698596092?location=LANDSCAPE", "publishedAt": "2021-12-17T00:11:20Z", "content": "Posted \r\nA panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccine\u2026 [+92 chars]"}], "2021-12-20": [{"source": {"id": null, "name": "NPR"}, "author": "Jaclyn Diaz", "title": "Moderna says its COVID booster increases protection against omicron", "description": "Moderna said its current FDA-approved 50-microgram booster shot increased antibody levels against omicron 37-fold compared to pre-booster levels.", "url": "https://www.npr.org/2021/12/20/1065734884/moderna-says-its-covid-booster-increases-protection-against-omicron", "urlToImage": "https://media.npr.org/assets/img/2021/12/20/ap21350469730902_wide-0d598730107da05c19468e3d800be749c0460327.jpg?s=1400", "publishedAt": "2021-12-20T11:11:33Z", "content": "Moderna said Monday preliminary data showed its COVID-19 booster shot is effective against the omicron variant of the coronavirus currently surging in the U.S. and around the world.\r\nThe pharmaceutic\u2026 [+904 chars]"}], "2021-12-23": [{"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition", "description": "Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.", "url": "http://www.zacks.com/stock/news/1842878/moderna-mrna-down-as-pfizer-paxlovid-eua-may-fuel-competition?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842878", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404475.jpeg", "publishedAt": "2021-12-23T15:39:00Z", "content": "Shares of popular COVID-19 vaccine-maker, ModernaMRNA were down 6.3% on Wednesday, following the news of emergency use authorization (EUA) for Pfizers PFE promising oral COVID-19 pill, Paxlovid, in t\u2026 [+7367 chars]"}], "2021-12-22": [{"source": {"id": null, "name": "Tbnewswatch.com"}, "author": "Leith Dunick", "title": "Health unit switching to mainly Moderna vaccines - Tbnewswatch.com", "description": "Health unit switching to mainly Moderna vaccines\u00a0\u00a0Tbnewswatch.comView Full coverage on Google News", "url": "https://www.tbnewswatch.com/coronavirus-covid-19-local-news/health-unit-switching-to-mainly-moderna-vaccines-4893157", "urlToImage": "https://www.vmcdn.ca/f/files/townandcountrytoday/images/moderna-vaccine.jpg;w=1200;h=800;mode=crop", "publishedAt": "2021-12-22T23:30:00Z", "content": "THUNDER BAY -- The Thunder Bay District Health Unit is switching to Moderna'sSpikeVax as its primary vaccine moving forward.\r\nThe health unit on Wdnesday said the move will be made mainly due to supp\u2026 [+1390 chars]"}], "2021-12-06": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Reuters", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response-uk-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/2hWWuQQtDAfsE2_em2jdEEeltMw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/P3XCTOZZEJKGRERRQ6XNXOCXUU.jpg", "publishedAt": "2021-12-06T23:40:00Z", "content": "Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots follow\u2026 [+3422 chars]"}], "2021-12-01": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna exec says company could have Omicron booster ready in March - Reuters", "description": "Moderna Inc <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wedn\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-exec-says-company-could-have-omicron-booster-ready-march-2021-12-01/", "urlToImage": "https://www.reuters.com/resizer/V-emukdLzpodyAgK9a6EjkNy6bU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZIV5R25AABINFPNCMEOPSZQP7U.jpg", "publishedAt": "2021-12-01T19:56:00Z", "content": "NEW YORK, Dec 1 (Reuters) - Moderna Inc (MRNA.O) could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's presi\u2026 [+3401 chars]"}], "2021-12-16": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer - Reuters", "description": "Japan on Thursday officially approved Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine for its booster shot programme that began this month.", "url": "https://www.reuters.com/world/asia-pacific/japan-adds-moderna-shot-covid-vaccine-booster-arsenal-joining-pfizer-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/DNWCKjP-UTc21x4Fij5lqVdfy-U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LXZ7Q7HUERO4LJ6MQSEN5X7GLE.jpg", "publishedAt": "2021-12-16T03:19:00Z", "content": "TOKYO, Dec 16 (Reuters) - Japan on Thursday officially approved Moderna Inc's (MRNA.O) COVID-19 vaccine for its booster shot programme that began this month.\r\nThe move followed a recommendation from \u2026 [+1316 chars]"}], "2021-12-21": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna could be ready to develop Omicron booster in weeks - CEO - Reuters", "description": "COVID-19 vaccine maker Moderna <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few we\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-could-be-ready-develop-omicron-booster-weeks-ceo-2021-12-21/", "urlToImage": "https://www.reuters.com/resizer/vFCsqhKPg-HAAWgX-qlg38-H9mk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L7LSITQGFBJWLHA756XMPIQYCU.jpg", "publishedAt": "2021-12-21T07:42:00Z", "content": "ZURICH, Dec 21 (Reuters) - COVID-19 vaccine maker Moderna (MRNA.O) does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin \u2026 [+2619 chars]"}], "2022-01-04": {"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Alex Carchidi and Taylor Carmichael)", "title": "Better Buy: Novavax vs. Moderna", "description": "Both of these coronavirus vaccine innovators have plenty of upside in 2022.", "url": "https://www.fool.com/investing/2022/01/04/better-buy-novavax-vs-moderna/", "urlToImage": "https://g.foolcdn.com/editorial/images/659510/worker-holds-coronavirus-vaccine-syringe.jpg", "publishedAt": "2022-01-04T11:08:00Z", "content": "Novavax(NASDAQ:NVAX) and Moderna(NASDAQ:MRNA) are two of the biotech industry's biggest success stories from the coronavirus vaccine race. While Moderna's market cap of around $104 billion makes Nova\u2026 [+5313 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Tomi Kilgore", "title": "Moderna shipped 800 million COVID vaccines last year, more than tripled its cash position but stock falls again", "description": "Moderna Inc. said in a letter to shareholders disclosed Tuesday, Chief Executive St\u00e9phane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-19 vaccine to more than 60 countries in 2021, and more than tripled the amount of \u2026", "url": "https://www.marketwatch.com/story/moderna-shipped-800-million-covid-vaccines-last-year-more-than-tripled-its-cash-position-but-stock-falls-again-2022-01-04", "urlToImage": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "publishedAt": "2022-01-04T13:22:50Z", "content": "Moderna Inc. \r\n MRNA,\r\n -7.45%\r\nsaid in a letter to shareholders disclosed Tuesday, Chief Executive St\u00e9phane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-19 \u2026 [+1133 chars]"}]}, "2022-01-03": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Interval between Moderna COVID-19 vaccine second shot and booster still six months -FDA - Reuters", "description": "The interval between receiving a second dose of Moderna's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food and Drug Administration Acting Commissione\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/interval-between-moderna-covid-19-vaccine-second-shot-booster-still-six-months-2022-01-03/", "urlToImage": "https://www.reuters.com/resizer/vFCsqhKPg-HAAWgX-qlg38-H9mk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L7LSITQGFBJWLHA756XMPIQYCU.jpg", "publishedAt": "2022-01-03T16:53:00Z", "content": "A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike SegarWASHINGTON, Jan 3 (Reuters) - The interval betwe\u2026 [+703 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Pfizer, BioNTech, and Moderna Stocks Are Falling Today", "description": "Investors appear to be seeing a future where COVID-19 vaccines aren't needed nearly as much.", "url": "https://www.fool.com/investing/2022/01/03/why-pfizer-biontech-and-moderna-stocks-are-falling/", "urlToImage": "https://g.foolcdn.com/editorial/images/659670/vaccine-being-given-to-a-young-man.jpg", "publishedAt": "2022-01-03T17:01:00Z", "content": "What happened\r\nShares of several leading COVID-19 vaccine makers were falling as of 11:38 a.m. ET on Monday. Pfizer(NYSE:PFE) stock was down 3.5%. Shares of BioNTech(NASDAQ:BNTX) and Moderna(NASDAQ:M\u2026 [+2692 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-omicron-pfizer-moderna-astrazeneca-b1985766.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-03T07:26:31Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "ACCESSWIRE", "title": "Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare Conference", "description": "CAMBRIDGE, MA / ACCESSWIRE / January 3, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...", "url": "https://finance.yahoo.com/news/moderna-business-pipeline-updates-2022-153000994.html", "urlToImage": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png", "publishedAt": "2022-01-03T15:30:00Z", "content": "CAMBRIDGE, MA / ACCESSWIRE / January 3, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO St\u00e9phane Bancel\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Tech Stock Pros", "title": "Moderna: Time To Hop Off The Pandemic Train. Looming Revenue Declines To Pressure The Stock", "description": "Moderna developed one of the three vaccines approved in the U.S. to prevent COVID-19. Read more to see why I think it's time to take profits at this valuation.", "url": "https://seekingalpha.com/article/4477633-moderna-time-to-hop-off-pandemic-train-looming-revenue-declines-to-pressure-the-stock", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303673692/large_image_1303673692.jpg", "publishedAt": "2022-01-03T07:08:50Z", "content": "carmengabriela/iStock Editorial via Getty Images\r\nModerna Inc. (NASDAQ:MRNA), a clinical-stage biotechnology company, develops therapeutics and vaccines based on messenger RNA to treat infectious and\u2026 [+6101 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster FAQ: When can you get a third dose?", "description": "The FDA just reduced the waiting period for COVID-19 vaccine boosters -- including Moderna's Spikevax -- but when and where can you get it and what are the side effects?", "url": "https://www.cnet.com/health/moderna-covid-booster-faq-side-effects-when-can-i-get/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-03T19:22:17Z", "content": "New research shows the Moderna vaccine to be the most effective booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO an\u2026 [+11439 chars]"}]}, "2022-01-02": {"status": "ok", "totalResults": 3, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-protection-omicron-pfizer-moderna-astrazeneca-b1985492.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-02T09:51:39Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster FAQ: Side effects, vaccine effectiveness, what to know about third dose - CNET", "description": "Get the latest on Moderna's COVID-19 booster shot and its fight against the omicron variant.", "url": "https://www.cnet.com/health/moderna-covid-booster-faq-side-effects-vaccine-effectiveness-what-to-know-about-third-dose/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-02T21:30:03Z", "content": "New research shows the Moderna vaccine to be the most effective booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO an\u2026 [+11815 chars]"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "Aoife Barry", "title": "Sitdown Sunday: Dolly Parton on donating money to the Moderna vaccine", "description": "Settle back in a comfy chair and sit back with some of the week\u2019s best longreads.", "url": "https://www.thejournal.ie/sitdown-sunday-longreadas-5641676-Jan2022/", "urlToImage": "https://img2.thejournal.ie/article/5641676/river/?height=400&version=5643854", "publishedAt": "2022-01-02T09:00:12Z", "content": "ITS A DAY of rest, and you may be in the mood for a quiet corner and a comfy chair.\r\nWeve hand-picked the weeks best reads for you to savour.\r\n1. Hello Dolly\r\nAn interview with the one and only Dolly\u2026 [+5561 chars]"}]}, "2022-01-01": {"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna booster FAQ: COVID shot side effects, vaccine effectiveness, what to know about third dose", "description": "A COVID-19 booster shot is a critical piece in the fight against the omicron variant.", "url": "https://www.cnet.com/health/moderna-booster-faq-covid-shot-side-effects-vaccine-effectiveness-what-to-know-about-third-dose/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-01T17:06:00Z", "content": "The Moderna COVID-19 booster shots contain a half-dose of the vaccine.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and \u2026 [+11808 chars]"}]}, "2021-12-31": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Bre Bradham", "title": "Moderna Stock Volatility Leads to Worst Month in Turbulent Year", "description": "(Bloomberg) -- It\u2019s been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the...", "url": "https://finance.yahoo.com/news/moderna-stock-volatility-leads-worst-174741766.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/CCzZ4HaagGRcfiOeXL2JTw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/a755b5019fecc550cc398df1f188ba17", "publishedAt": "2021-12-31T17:47:41Z", "content": "(Bloomberg) -- Its been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.\r\nMost Read from Bloo\u2026 [+2471 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "The Associated Press", "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday: Moderna, Signature bank rise; GameStop, PayPal fall", "url": "https://abcnews.go.com/Business/wireStory/moderna-signature-bank-rise-gamestop-paypal-fall-82024667", "urlToImage": "null", "publishedAt": "2021-12-31T21:53:45Z", "content": "Stocks that traded heavily or had substantial price changes Friday:\r\nModerna, up $2.38 to $253.98\r\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdv\u2026 [+848 chars]"}, {"source": {"id": null, "name": "Minneapolis Star Tribune"}, "author": "Star Tribune Staff", "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday:", "url": "https://www.startribune.com/moderna-signature-bank-rise-gamestop-paypal-fall/600131700/", "urlToImage": "https://assets.startribune.com/static/img/branding/logos/strib-social-card.png?d=1640904844", "publishedAt": "2021-12-31T21:53:00Z", "content": "Stocks that traded heavily or had substantial price changes Friday:\r\nModerna, up $2.38 to $253.98\r\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdv\u2026 [+850 chars]"}, {"source": {"id": null, "name": "seattlepi.com"}, "author": null, "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday:\nModerna, up $2.38 to $253.98\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\nAdvanced Micro Devices, down $1.25 to $143.90\nThe company said it \u2026", "url": "https://www.seattlepi.com/business/article/Moderna-Signature-bank-rise-GameStop-PayPal-16741022.php", "urlToImage": "https://www.seattlepi.com/img/pages/article/opengraph_default.png", "publishedAt": "2021-12-31T22:06:03Z", "content": "The vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdvanced Micro Devices, down $1.25 to $143.90\r\nThe company said it was making progress on getting regu\u2026 [+749 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Breanna Bradham", "title": "Moderna Stock Volatility Leads to Worst Month in Turbulent Year - Bloomberg", "description": "It\u2019s been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.", "url": "https://www.bloomberg.com/news/articles/2021-12-31/moderna-stock-volatility-leads-to-worst-month-in-turbulent-year", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/irE4fmnkemsU/v2/1200x675.png", "publishedAt": "2021-12-31T17:47:41Z", "content": "Its been a wild ride for \r\nModerna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.\r\nModerna has slumped 27% in a mon\u2026 [+298 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna booster: UK says Moderna tops Pfizer in protection against omicron", "description": "COVID-19 boosters shots have become essential in the fight against the omicron variant. New stats support Moderna as the best choice.", "url": "https://www.cnet.com/health/moderna-booster-uk-stats-show-moderna-tops-pfizer-in-protection-against-omicron/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2021-12-31T19:00:03Z", "content": "The Moderna COVID-19 booster shots contain a half-dose of the vaccine.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and \u2026 [+13060 chars]"}]}, "2021-12-30": {"status": "ok", "totalResults": 4, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer, BioNTech, and Moderna Shot Higher Today", "description": "One coronavirus vaccine will apparently be authorized as a booster for younger people in the U.S.", "url": "https://www.fool.com/investing/2021/12/30/why-pfizer-biontech-and-moderna-shot-higher-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/659417/gloved-hand-filling-a-syringe-from-a-vial.jpg", "publishedAt": "2021-12-30T23:15:43Z", "content": "What happened\r\nThree of the top coronavirus stocks, Pfizer(NYSE:PFE), BioNTech(NASDAQ:BNTX), and Moderna(NASDAQ:MRNA), saw plenty of action on the market Thursday. Encouraging news for Pfizer and Bio\u2026 [+1502 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster: Does it work better than Pfizer's vaccine? - CNET", "description": "Booster shots have become critical in the fight against the omicron variant of COVID-19. How effective is Moderna's booster?", "url": "https://www.cnet.com/health/moderna-covid-booster-does-it-work-better-than-pfizers-vaccine/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2021-12-30T18:00:10Z", "content": "Moderna reports a 37-fold increase in \"omicron-neutralizing antibodies\" for those receiving the half-dose booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about \u2026 [+12642 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Study of Pfizer & Moderna vaccines against Omicron shows they have NEGATIVE effectiveness!", "description": null, "url": "https://www.investmentwatchblog.com/study-of-pfizer-moderna-vaccines-against-omicron-shows-they-have-negative-effectiveness/", "urlToImage": null, "publishedAt": "2021-12-30T14:02:21Z", "content": "I kid you not, the last line of the study is still these findings highlight the need for massive rollout of vaccinations and booster vaccinations.\r\n\u2014 Ezra Levant (@ezralevant) December 23, 2021\r\nSHOC\u2026 [+118 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "Thinking about trading options or stock in Alibaba, Advanced Micro Devices, Moderna, Walmart, or Dollar General?", "description": "NEW YORK, Dec. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, AMD, MRNA, WMT, and DG. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas\u2026", "url": "https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-alibaba-advanced-micro-devices-moderna-walmart-or-dollar-general-301451928.html", "urlToImage": "https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg?p=facebook", "publishedAt": "2021-12-30T15:57:00Z", "content": "NEW YORK, Dec. 30, 2021 /PRNewswire/ --\u00a0InvestorsObserver\u00a0issues critical PriceWatch Alerts for BABA, AMD, MRNA, WMT, and DG.\r\nClick a link below then choose between in-depth options trade idea repor\u2026 [+796 chars]"}]}, "2021-12-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2022-01-18": {"status": "ok", "totalResults": 8, "articles": [{"source": {"id": null, "name": "CNA"}, "author": null, "title": "COVID-flu joint booster jab possible late 2023: Moderna", "description": "GENEVA: Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said on Monday (Jan 17), hoping a joint jab would encourage people to get an annual shot.\r\n\r\nThe single vaccine for COVID-19, influenza and resp\u2026", "url": "https://www.channelnewsasia.com/world/moderna-covid-19-flu-booster-jab-2441981", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--NWylABoO--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:afp_watermark%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/31e2b43e91fb1a76601f45bf15cfb7c6fb9553f3.jpg?itok=VXy_HDWU", "publishedAt": "2022-01-18T02:41:00Z", "content": "GENEVA: Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said on Monday (Jan 17), hoping a joint jab would encourage people to get an annual \u2026 [+2614 chars]"}, {"source": {"id": null, "name": "Fontspace.com"}, "author": "pailystudio", "title": "Oliver Moderna by pailystudio", "description": "Free download of Oliver Moderna Font. Released in 2021 by pailystudio and licensed for personal-use only. Click now to create a custom image with your own words that you can download.", "url": "https://www.fontspace.com/oliver-moderna-font-f73351", "urlToImage": "https://img.fontspace.co/gallery/1200x800/5/f3ca27bf72b74acbb1765f6a683ebc3d.jpg", "publishedAt": "2022-01-18T07:32:54Z", "content": "Introducing by Paily Studio!\r\nOliver Moderna is a Modern Handwritten Font\r\nOliver Moderna is a magical handwritten font carefully created with a touch of boldness and elegance. Whether youre looking \u2026 [+205 chars]"}, {"source": {"id": null, "name": "Business Today"}, "author": "Reuters", "title": "Omicron-specific vaccine may be available in March, says Moderna CEO", "description": "&quot;The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps,&quot; Bancel said at the World Economic Forum's virtual Davos A\u2026", "url": "https://www.businesstoday.in/coronavirus/story/omicron-specific-vaccine-may-be-available-in-march-says-moderna-ceo-319430-2022-01-18", "urlToImage": "https://akm-img-a-in.tosshub.com/businesstoday/images/story/202201/moderna-vaccine-sixteen_nine.jpg", "publishedAt": "2022-01-18T06:41:07Z", "content": "Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around M\u2026 [+1784 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Jordan Dixon-Hamilton", "title": "Moderna Aims to Launch \u2018Flurona\u2019 Vaccine Booster to Treat Coronavirus and Flu in 2023", "description": "Moderna is aiming to launch a single-shot vaccine booster to treat both coronavirus and influenza as soon as fall of 2023, according to CEO Stephane Bancel.", "url": "https://www.breitbart.com/politics/2022/01/17/moderna-aims-launch-flurona-vaccine-booster-treat-coronavirus-flu-2023/", "urlToImage": "https://media.breitbart.com/media/2021/06/GettyImages-1233634029-640x335.jpg", "publishedAt": "2022-01-18T06:25:30Z", "content": "Moderna is aiming to launch a single-shot vaccine booster to treat both coronavirus and influenza as soon as fall of 2023, according to CEO Stephane Bancel.\r\nOur goal is to be able to have a single a\u2026 [+1600 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Live news: Combined flu and Covid vaccine available in 2023, says Moderna chief - Financial Times", "description": "Live news: Combined flu and Covid vaccine available in 2023, says Moderna chiefFinancial Times Moderna Working On Single Shot That Covers Both COVID & FluCBS Miami Moderna CEO says data for Omicron-specific shot likely available in MarchYahoo News The latest \u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157803023", "urlToImage": null, "publishedAt": "2022-01-18T02:32:54Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna aims to launch single Covid and flu booster jab within two years - The Guardian", "description": "Moderna aims to launch single Covid and flu booster jab within two yearsThe Guardian Moderna CEO says data for Omicron-specific shot likely available in MarchYahoo News Moderna Working On Single Shot That Covers Both COVID & FluCBS Miami The latest on the cor\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157805163", "urlToImage": null, "publishedAt": "2022-01-18T04:13:55Z", "content": "You may call me by my name, Wirth, or by my value, Worth.\r\n- Nicklaus Wirth"}, {"source": {"id": null, "name": "Philippine Star"}, "author": "Robin Millard", "title": "COVID-flu joint booster jab possible late 2023 \u00e2\u0080\u0094 Moderna", "description": "Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.", "url": "https://www.philstar.com/lifestyle/health-and-family/2022/01/18/2154690/covid-flu-joint-booster-jab-possible-late-2023-moderna", "urlToImage": "https://media.philstar.com/photos/2021/10/15/moderna-vax_2021-10-15_10-17-33.jpg", "publishedAt": "2022-01-18T02:11:40Z", "content": "GENEVA, Switzerland \u2014 Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annua\u2026 [+2623 chars]"}, {"source": {"id": null, "name": "Euronews"}, "author": "Tom Bateman", "title": "Seasonal COVID and flu booster vaccines will become the norm after Omicron, say Moderna and Pfizer", "description": "Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years.", "url": "https://www.euronews.com/next/2022/01/18/seasonal-covid-and-flu-booster-vaccines-will-become-the-norm-after-omicron-say-moderna-and", "urlToImage": "https://static.euronews.com/articles/stories/06/38/98/78/1000x563_cmsv2_ec636300-8fa4-5af4-a18d-6f44e5f5defa-6389878.jpg", "publishedAt": "2022-01-18T10:45:00Z", "content": "COVID-19 vaccines will be here for the long-term, and could become part of the annual range of booster shots offered, leading vaccine makers predicted on Monday.\r\nCOVID-19 mRNA vaccine manufacturers \u2026 [+1838 chars]"}]}, "2022-01-17": {"status": "ok", "totalResults": 17, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna CEO says data for Omicron-specific shot likely available in March - Reuters", "description": "Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-ceo-says-data-omicron-specific-shot-likely-available-march-2022-01-17/", "urlToImage": "https://www.reuters.com/resizer/y-ZRZ7vKDAi4b-3niNgivvOs5mI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/TTXUNTY7MRJNDAOZFO3E2SF4SU.jpg", "publishedAt": "2022-01-17T14:05:00Z", "content": "Jan 17 (Reuters) - Moderna Inc's (MRNA.O) vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share d\u2026 [+2067 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Barbara Kollmeyer", "title": ": Moderna aims for COVID/flu booster in 2023, but Fauci and other virus experts warn of challenges to come this year", "description": "A panel of virus experts and Moderna's CEO Stephane Bancel gathered Monday in a virtual panel to discuss pandemic challenges and possible developments ahead for 2022.", "url": "https://www.marketwatch.com/story/moderna-aims-for-covid-flu-booster-in-2023-but-fauci-and-other-virus-experts-warn-of-challenges-to-come-this-year-11642433642", "urlToImage": "https://images.mktw.net/im-468998/social", "publishedAt": "2022-01-17T15:34:00Z", "content": "Modernas chief executive officer Stephane Bancel said the company hopes to have a combined flu and COVID vaccine ready for 2023, but virus experts speaking on a panel Monday poured cold water on the \u2026 [+3934 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino)", "title": "Is Moderna Stock Too Expensive in 2022?", "description": "It's important to look at vaccine sales prospects -- and potential future products.", "url": "https://www.fool.com/investing/2022/01/17/is-moderna-stock-too-expensive-in-2022/", "urlToImage": "https://g.foolcdn.com/editorial/images/661517/gettyimages-1167803904.jpg", "publishedAt": "2022-01-17T11:00:00Z", "content": "Moderna(NASDAQ:MRNA) stock has soared for the past two years thanks to its leadership in the coronavirus vaccine market. It's gained 1,200% over that time period. First, investors bet on the company'\u2026 [+4308 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Mark Sweney", "title": "Moderna aims to launch single Covid and flu booster jab within two years", "description": "Combined vaccine should be ready in time for winter infectious season in 2023, says drug firm\u2019s chief executiveModerna is aiming to launch a single booster vaccination that will protect against both Covid-19 and flu within two years, its chief executive has s\u2026", "url": "https://amp.theguardian.com/business/2022/jan/17/moderna-aims-to-launch-single-covid-and-flu-booster-jab-within-two-years", "urlToImage": "https://i.guim.co.uk/img/media/7365f97549aa53a257b26d14b7066e790dc098ec/0_84_3500_2099/master/3500.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=512e5456dcf3254ce42234f9cd1aac3b", "publishedAt": "2022-01-17T17:46:24Z", "content": "Moderna is aiming to launch a single booster vaccination that will protect against both Covid-19 and flu within two years, its chief executive has said.\r\nSt\u00e9phane Bancel said that the combined vaccin\u2026 [+2553 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Moderna CEO says data for Omicron-specific shot likely available in March", "description": "Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.  Bancel said the best case scenario...", "url": "https://news.yahoo.com/moderna-ceo-says-data-omicron-140546255.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/V7zCtp7oxR_GdpF7zyKphQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/1de29d73903fccaea091db669f09ba46", "publishedAt": "2022-01-17T14:05:46Z", "content": "(Reuters) - Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulat\u2026 [+1889 chars]"}, {"source": {"id": null, "name": "POLITICO.eu"}, "author": "Douglas Busvine", "title": "Moderna hopes to market combined COVID and flu booster in 2023", "description": "Single-shot booster would also protect against RSV, offering protection against respiratory viruses with a single shot before winter.", "url": "http://www.politico.eu/article/moderna-hopes-to-market-combined-covid-and-flu-booster-in-2023/", "urlToImage": "https://www.politico.eu/wp-content/uploads/2022/01/17/GettyImages-1230790502-1200x628.jpg", "publishedAt": "2022-01-17T13:40:08Z", "content": "Moderna hopes to market a combined booster vaccination for COVID-19, influenza and RSV a common respiratory virus \u00a0as soon as the fall of 2023, CEO St\u00e9phane Bancel said Monday.\r\nBancel, speaking on a\u2026 [+1434 chars]"}, {"source": {"id": "news-com-au", "name": "News.com.au"}, "author": "Frank Chung", "title": "Booster vaccine: TGA confirms first cases of myocarditis, pericarditis after Pfizer, Moderna | news.com.au \u2014 Australia's leading news site - NEWS.com.au", "description": "<ol><li>Booster vaccine: TGA confirms first cases of myocarditis, pericarditis after Pfizer, Moderna | news.com.au \u2014 Australia's leading news site\u00a0\u00a0NEWS.com.au\r\n</li><li>Omicron: Three 'serious side effects' of the Covid booster \u2013 seek medical help 'urgently'\u2026", "url": "https://www.news.com.au/lifestyle/health/health-problems/tga-confirms-first-cases-of-myocarditis-linked-to-booster-shots/news-story/a0211e1242c66366e21d83a54aa7a298", "urlToImage": "https://content.api.news/v3/images/bin/4fec9f32c0b012a4394ee971b1965512", "publishedAt": "2022-01-17T01:43:48Z", "content": "Australias medicines regulator has confirmed the first cases of rare heart inflammation after booster vaccines.Australia\u2019s medicines regulator has confirmed the first cases of rare heart inflammation\u2026 [+6350 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Reuters", "title": "Moderna CEO says data for Omicron-specific shot likely available in March", "description": "\"The vaccine is being finished, it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps,\" Bancel said at the World Economic Forum's virtual Davos Agenda confere\u2026", "url": "https://timesofindia.indiatimes.com/world/us/moderna-ceo-says-data-for-omicron-specific-shot-likely-available-in-march/articleshow/88956320.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-88956331,width-1070,height-580,imgsize-25288,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2022-01-17T13:58:44Z", "content": "Moderna CEO says data for Omicron-specific shot likely available in March"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Star Investments", "title": "Moderna: High Upside Potential At Current Prices", "description": "Moderna has a significant first-mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity.", "url": "https://seekingalpha.com/article/4479930-moderna-high-upside-potential-at-current-prices", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288670269/medium_image_1288670269.jpg", "publishedAt": "2022-01-17T07:27:23Z", "content": "Maddie Meyer/Getty Images News\r\nModerna (NASDAQ: MRNA) has extremely high upside from being a first mover in developing the world's most advanced mRNA platform. One of the most promising potential so\u2026 [+18468 chars]"}, {"source": {"id": null, "name": "FRANCE 24 English"}, "author": "FRANCE24", "title": "Covid-flu joint booster jab possible late 2023: Moderna", "description": "The single vaccine for Covid-19, influenza and respiratory syncytial virus -- a common virus that causes the cold, but can be more serious for infants and elderly people -- could appear on the market before 2024.\n\n\"Best-case scenario will be the fall of '23,\"\u2026", "url": "https://www.france24.com/en/live-news/20220117-covid-flu-joint-booster-jab-possible-late-2023-moderna", "urlToImage": "https://s.france24.com/media/display/b183e552-77b4-11ec-bbad-005056bf30b7/w:1280/p:16x9/0287721f33804297c36f08d5f8873d97932e027e.jpg", "publishedAt": "2022-01-17T16:44:12Z", "content": "Geneva (AFP) Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. T\u2026 [+2624 chars]"}, {"source": {"id": null, "name": "The Straits Times"}, "author": "Hermes Auto", "title": "Covid-flu joint booster jab possible late 2023: Moderna", "description": "The experimental flu shot is based on the same mRNA method used in its Covid-19 jabs.\n. Read more at straitstimes.com.", "url": "https://www.straitstimes.com/world/europe/covid-flu-joint-booster-jab-possible-late-2023-moderna", "urlToImage": "https://static1.straitstimes.com.sg/s3fs-public/styles/large30x20/public/articles/2022/01/18/btmoderna20220117.jpg?VersionId=MdzIJO5_PoxQvtW8CAoBaCooSk5DxpO2", "publishedAt": "2022-01-17T20:23:31Z", "content": "GENEVA (AFP) - Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday (Jan 17), hoping a joint jab would encourage people to get an ann\u2026 [+2000 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer and Moderna expect seasonal booster shots after omicron wave", "description": "Seasonal COVID boosters may be combined with flu shots in the future, Moderna says.", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157799191", "urlToImage": null, "publishedAt": "2022-01-17T23:32:30Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna hopes to market combined COVID and flu booster in 2023 - POLITICO Europe", "description": "Moderna hopes to market combined COVID and flu booster in 2023POLITICO Europe Moderna CEO says data for Omicron-specific shot likely available in MarchYahoo News Moderna Targets Fall 2023 for Covid-Flu Combo VaccineBarron's Live news: Combined Covid and flu v\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157790747", "urlToImage": null, "publishedAt": "2022-01-17T17:13:21Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna CEO says data for Omicron-specific shot likely available in March - Yahoo News", "description": "Moderna CEO says data for Omicron-specific shot likely available in MarchYahoo News Moderna hopes to market combined COVID and flu booster in 2023POLITICO Europe Moderna aims for COVID/flu booster in 2023, but Fauci and other virus experts warn of challenges \u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157794085", "urlToImage": null, "publishedAt": "2022-01-17T19:33:30Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": "news-com-au", "name": "News.com.au"}, "author": "Ellen Ransley", "title": "Children\u2019s vaccine rollout: Moderna being considered by TGA", "description": "<p>Children under 12 could soon have access to the Moderna Covid-19 vaccine, as the immunisation program ramps up across Australia. </p>", "url": "https://www.news.com.au/technology/science/greg-hunt-says-moderna-to-submit-data-to-tga-for-childrens-vaccination/news-story/e9b60115478afb2fe80be9c19e15920d", "urlToImage": "https://content.api.news/v3/images/bin/66f25c7f1f89efeac409c79d202a2146", "publishedAt": "2022-01-17T01:35:51Z", "content": "Parents could soon have another option to vaccinate children against Covid with Australias medical regulator set to make a huge call.Children under 12 could soon have access to the Moderna Covid-19 v\u2026 [+2624 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": "Reuters", "title": "Omicron-specific shot data likely coming in March: Moderna", "description": "Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.", "url": "https://www.ctvnews.ca/health/coronavirus/moderna-ceo-says-data-for-omicron-specific-shot-likely-available-in-march-1.5742830", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5742843.1642433332!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-17T15:39:50Z", "content": "Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around M\u2026 [+1850 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna aims for COVID/flu booster in 2023, but Fauci and other virus experts warn of challenges to come this year - MarketWatch", "description": "Moderna aims for COVID/flu booster in 2023, but Fauci and other virus experts warn of challenges to come this yearMarketWatch Moderna CEO says data for Omicron-specific shot likely available in MarchYahoo News Moderna hopes to market combined COVID and flu bo\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157793129", "urlToImage": null, "publishedAt": "2022-01-17T18:52:59Z", "content": "FORTRAN is not a flower but a weed -- it is hardy, occasionally blooms,\r\nand grows in every computer.\r\n-- A.J. Perlis"}]}, "2022-01-16": {"status": "ok", "totalResults": 4, "articles": [{"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "'Choose increased antibodies over brand': Moderna appointments still being cancelled in London, Ont. area - CTV News London", "description": "<ol><li>'Choose increased antibodies over brand': Moderna appointments still being cancelled in London, Ont. area\u00a0\u00a0CTV News London\r\n</li><li>Ontario LTCs uneasy about approaching booster mandate deadline amid Omicron wave\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><\u2026", "url": "https://london.ctvnews.ca/choose-increased-antibodies-over-brand-moderna-appointments-still-being-cancelled-in-london-ont-area-1.5742242", "urlToImage": "https://www.ctvnews.ca/content/dam/ctvnews/en/images/2022/1/16/moderna-covid-19-vaccine-1-5742244-1642371495315.jpg", "publishedAt": "2022-01-16T22:23:00Z", "content": "Doctors and pharmacists continue to advocate for people to get the first available mRNA vaccine for their COVID-19 booster dose.\r\n \"We have had some feedback that appointments are being canceled beca\u2026 [+2597 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights and Brian Orelli, PhD)", "title": "When Will Moderna Stock Be a Screaming Buy?", "description": "The stock needs to move even lower.", "url": "https://www.fool.com/investing/2022/01/16/when-will-moderna-stock-be-a-screaming-buy/", "urlToImage": "https://g.foolcdn.com/editorial/images/661162/vaccine-vial-with-a-dollar-sign-in-it.jpg", "publishedAt": "2022-01-16T11:54:00Z", "content": "Moderna(NASDAQ:MRNA) is now far below its peak market cap last summer of nearly $200 billion. But when will the vaccine stock be a screaming buy for investors?\u00a0In this Motley Fool Live video recorded\u2026 [+2715 chars]"}, {"source": {"id": null, "name": "Newspunch.com"}, "author": "Mike Rivero", "title": "Smoking Gun: Moderna Patented \u2018Man Made\u2019 SARS-CoV2 Gene Sequence in 2018", "description": "The SARS-CoV-2 genome contains an unusual 19 nucleotide sequence found nowhere else in nature \u2013 apart from in Moderna patents submitted in 2018.", "url": "https://newspunch.com/smoking-gun-moderna-patented-man-made-sars-cov2-gene-sequence-in-2018/", "urlToImage": "https://cdn.newspunch.com/wp-content/uploads/2022/01/Moderna-1-scaled-1200x630-cropped.jpg.webp", "publishedAt": "2022-01-16T15:13:48Z", "content": "The SARS-CoV-2 genome contains an unusual 19 nucleotide sequence found nowhere else in nature \u2013 apart from in Moderna patents submitted in 2018. \r\nSARS-CoV-2 genome contains a 19 nucleotide sequence \u2026 [+16060 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Aidan Wondracz", "title": "Covid-19 Australia: Moderna vaccine being considered for children five to 11", "description": "Children aged six to 11 are currently only eligible for the Pfizer vaccine with more than 300,000 receiving their dose since the rollout began last Monday.", "url": "https://www.dailymail.co.uk/news/article-10408579/Covid-19-Australia-Moderna-vaccine-considered-children-five-11.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/16/20/53001437-0-image-a-3_1642366583853.jpg", "publishedAt": "2022-01-16T21:27:05Z", "content": "Children aged between six and 11 could soon have access to a second vaccine with Moderna set to be made available in a matter of weeks.\r\nThe age group is currently only eligible for the Pfizer vaccin\u2026 [+3603 chars]"}]}, "2022-01-15": {"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "En-volve.com"}, "author": "IamShado", "title": "Smoking Gun: Moderna Patented \u2018Man Made\u2019 SARS-CoV2 Gene Sequence Two Years BEFORE Pandemic Started", "description": "The SARS-CoV-2 genome contains an unusual 19 nucleotide sequence found nowhere else in nature \u2013 apart from in Moderna patents submitted in 2018. \n\n\n\nSARS-CoV-", "url": "https://en-volve.com/2022/01/15/smoking-gun-moderna-patented-man-made-sars-cov2-gene-sequence-two-years-before-pandemic-started/", "urlToImage": "http://en-volve.com/wp-content/uploads/2022/01/Moderna-1-678x381.jpg.optimal.jpg", "publishedAt": "2022-01-15T19:04:44Z", "content": "The SARS-CoV-2 genome contains an unusual 19 nucleotide sequence found nowhere else in nature apart from in Moderna patents submitted in 2018. \r\nSARS-CoV-2 genome contains a 19 nucleotide sequence #C\u2026 [+15956 chars]"}]}, "2022-01-14": {"status": "ok", "totalResults": 14, "articles": [{"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Covid Pandemic May Shift to Endemic in 2022, Moderna Chair Says", "description": "The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the omicron variant spreads, according to Moderna Inc. co-founder Noubar Afeyan.", "url": "https://www.bloomberg.com/news/articles/2022-01-14/moderna-chair-says-covid-pandemic-may-shift-to-endemic-in-2022-kyecqioq", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/izfjbPumPQgE/v1/1200x801.jpg", "publishedAt": "2022-01-14T12:03:18Z", "content": "The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the omicron variant spreads, according to \r\nModerna Inc. co-founder Noubar Afeyan.\r\nWhile\u2026 [+187 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Robert Hart, Forbes Staff, \n Robert Hart, Forbes Staff\n https://www.forbes.com/sites/roberthart/", "title": "Moderna Starts Human Trials Of mRNA Vaccine For Virus That Likely Causes Multiple Sclerosis", "description": "Almost all adults have been infected by the Epstein-Barr virus, which scientists believe is the likely cause of multiple sclerosis, a potentially disabling neurological condition.", "url": "https://www.forbes.com/sites/roberthart/2022/01/14/moderna-starts-human-trials-of-mrna-vaccine-for-virus-that-likely-causes-multiple-sclerosis/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61e1b3ab32590f3911fff303%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D5457%26cropY1%3D159%26cropY2%3D3228", "publishedAt": "2022-01-14T17:34:52Z", "content": "Moderna recently launched early stage clinical trials for an mRNA vaccine against the Epstein-Barr virus (EBV), a common pathogen that infects almost everyone at some point in their lives, is the pri\u2026 [+2781 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Sabrina Escobar", "title": "Moderna, Novavax, and Other Vaccine Stocks Get Whacked by Supreme Court\u2019s Vaccine Decision", "description": "Shares of the biotech stocks are getting hit hard after the ruling blocked President Biden's mandate.", "url": "https://www.barrons.com/articles/moderna-novavax-vaccine-stocks-supreme-court-51642165803", "urlToImage": "https://images.barrons.com/im-410080/social", "publishedAt": "2022-01-14T14:41:00Z", "content": "Novavax\r\nstock and shares of other vaccine makers fell Friday after the Supreme Court blocked the Biden administrations vaccine mandate for companies that employ 100 workers or more. Its just one mor\u2026 [+3611 chars]"}, {"source": {"id": null, "name": "Fark.com"}, "author": null, "title": "Moderna chair says this could be the year that Covid-19 becomes endemic, although Pfizer's footstool and the Johnson & Johnson ottoman have not yet weighed in [Interesting]", "description": "Moderna chair says this could be the year that Covid-19 becomes endemic, although Pfizer's footstool and the Johnson & Johnson ottoman have not yet weighed in", "url": "https://www.fark.com/comments/12054986/Moderna-chair-says-this-could-be-year-that-Covid-19-becomes-endemic-although-Pfizers-footstool-the-Johnson-Johnson-ottoman-have-not-yet-weighed-in", "urlToImage": "https://usrimg-full.fark.net/Z/Z1/fark_Z11Dt3Kj65xQWPIbYdHsfMsysNE.jpg?AWSAccessKeyId=HBAYEKZHGUB4NAYQBVSQ&Expires=1642395600&Signature=hnXcEmr2kYW18YclysWdZxQxYO4%3D", "publishedAt": "2022-01-14T18:12:16Z", "content": "Gubbo:odinsposse: plecos: Nadie_AZ: They want this. It is more profitable for them to let the asteroid get closer to earth so they can break it up into manageable pieces so they can mine them for mor\u2026 [+637 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Kyle LaHucik", "title": "'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter", "description": "Written in the middle of the largest pandemic wave to-date, Flagship Pioneering CEO and Moderna Chairman Noubar Afeyan, Ph.D., penned his first annual letter documenting the sea changes in biotech. He also called on more preemptive measures for future pandemi\u2026", "url": "https://www.fiercebiotech.com/biotech/shots-goal-to-deterministic-drug-development-flagship-ceo-moderna-chair-noubar-afeyan-pens", "urlToImage": "https://qtxasset.com/fiercebiotech/1642174351/flagship.jpg/flagship.jpg?VersionId=1xfMTlBACnfLd0SNptvB9og5NdcBqQP7", "publishedAt": "2022-01-14T15:33:14Z", "content": "The founder of Modernas incubator, Flagship Pioneering, penned his first\u00a0annual letter charting the four driving forces behind the biotech industrys future with an emphasis on digital biology and pla\u2026 [+6175 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Bloomberg", "title": "Pandemia podr\u00eda pasar a endemia en 2022: Cofundador de Moderna", "description": "(Bloomberg) -- La pandemia podr\u00eda comenzar a pasar a una fase end\u00e9mica en 2022, aunque los pa\u00edses deber\u00e1n permanecer atentos a medida que se propaga la variante \u00f3micron, seg\u00fan el cofundador de Moderna Inc. Noubar Afyan.Most Read from BloombergCannabis Compoun\u2026", "url": "https://es-us.finanzas.yahoo.com/noticias/pandemia-pasar-endemia-2022-cofundador-124121432.html", "urlToImage": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png", "publishedAt": "2022-01-14T12:41:21Z", "content": "(Bloomberg) -- La pandemia podr\u00eda comenzar a pasar a una fase end\u00e9mica en 2022, aunque los pa\u00edses deber\u00e1n permanecer atentos a medida que se propaga la variante \u00f3micron, seg\u00fan el cofundador de Modern\u2026 [+1834 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Carla Moz\u00e9e)", "title": "Moderna and Novavax extend losses after Supreme Court strikes down Biden's vaccine mandate for private employers", "description": "The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld a mandate for healthcare workers.", "url": "https://markets.businessinsider.com/news/stocks/moderna-novavax-stock-price-drop-supreme-court-biden-vaccine-mandate-2022-1", "urlToImage": "https://images2.markets.businessinsider.com/618a696b23745d0018259f47?format=jpeg", "publishedAt": "2022-01-14T14:15:30Z", "content": "A woman in San Antonio, Texas, receives her second Moderna COVID-19 vaccine shot.Sergio Flores/Getty Images\r\nShares of Novavax and Moderna each dropped Friday, with stock in the COVID-19 vaccine make\u2026 [+1322 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "Vaccine stocks in red, Moderna Chair says COVID pandemic could move into endemic phase in 2022", "description": "carmengabriela/iStock Editorial via Getty Images COVID-19 vaccine makers' shares edge lower in premarket trading, with Novavax (NASDAQ:NVAX) leading the losses,\u00a0down 10.4%, after falling...", "url": "https://seekingalpha.com/news/3788243-vaccine-stocks-in-red-moderna-chair-says-covid-pandemic-could-move-into-endemic-phase-in-2022", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303673684/medium_image_1303673684.jpg", "publishedAt": "2022-01-14T13:04:18Z", "content": "carmengabriela/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "RV Malone MD, Substack", "title": "\"How Bad is my Batch\" The story of my vaccine injury (Moderna Vax)", "description": "In fact, I do have a personal life. My wife of of 42 years and I are actually pretty private. Sharing personal history is not something I do everyday. However, as many of you know - I was vaccinated with Moderna twice and had a pretty significant vaccine inju\u2026", "url": "https://freerepublic.com/focus/f-bloggers/4029312/posts", "urlToImage": null, "publishedAt": "2022-01-14T01:31:54Z", "content": "Skip to comments.\r\n\"How Bad is my Batch\" The story of my vaccine injury (Moderna Vax)RV Malone MD, Substack ^\r\n | January 13, 2022\r\n | Robert W. Malone MD, MS\r\nPosted on 01/13/2022 5:31:54 PM PST by \u2026 [+2565 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "James Paton | Bloomberg", "title": "Covid may shift to endemic in 2022, says Moderna co-founder", "description": "World Health Organization officials have said it's too early to make that call as cases surge", "url": "https://www.business-standard.com/article/international/covid-may-shift-to-endemic-in-2022-says-moderna-co-founder-122011401503_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2022-01/14/full/1642183651-9657.png", "publishedAt": "2022-01-14T18:09:00Z", "content": "The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the omicron variant spreads, according to Moderna Co-founder Noubar Afeyan.\r\nWhile some c\u2026 [+3774 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "Thinking about trading options or stock in MGM Resorts, General Electric, Carnival Corp, AT&T, or Moderna?", "description": "NEW YORK, Jan. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MGM, GE, CCL, T, and MRNA. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on\u2026", "url": "https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-mgm-resorts-general-electric-carnival-corp-att-or-moderna-301461247.html", "urlToImage": "https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg?p=facebook", "publishedAt": "2022-01-14T14:31:00Z", "content": "NEW YORK, Jan. 14, 2022 /PRNewswire/ --\u00a0InvestorsObserver\u00a0issues critical PriceWatch Alerts for MGM, GE, CCL, T, and MRNA.\r\nClick a link below then choose between in-depth options trade idea report o\u2026 [+793 chars]"}, {"source": {"id": null, "name": "The Straits Times"}, "author": "Hermes Auto", "title": "Covid-19 pandemic may shift to endemic in 2022, Moderna chair says", "description": "But it really depends on what happens and the decisions that are made across the world, he added.\n. Read more at straitstimes.com.", "url": "https://www.straitstimes.com/world/united-states/covid-19-pandemic-may-shift-to-endemic-in-2022-moderna-chair-says", "urlToImage": "https://static1.straitstimes.com.sg/s3fs-public/styles/large30x20/public/articles/2022/01/14/hzcovid140122.jpg?VersionId=EWxnozEVsdGO83yiBA1GKOJPIcLhL1hd", "publishedAt": "2022-01-14T13:02:48Z", "content": "MASSACHUSETTES, New England (BLOOMBERG) - The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the Omicron variant spreads, according to Moder\u2026 [+1554 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pandemic to endemic? Moderna chair says it could happen this year - Aljazeera.com", "description": "Moderna co-founder tells Bloomberg News that 2022 may be the year the pandemic enters the endemic phase.", "url": "https://www.aljazeera.com/economy/2022/1/14/pandemic-to-endemic-moderna-chair-says-it-could-happen-this-year", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2022/01/382922403.jpg?resize=1200%2C630", "publishedAt": "2022-01-14T13:40:32Z", "content": "The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the omicron variant spreads, according to Moderna Inc. co-founder Noubar Afeyan.\r\nWhile\u00a0s\u2026 [+1475 chars]"}, {"source": {"id": null, "name": "Livemint"}, "author": "Bloomberg", "title": "Covid-19 pandemic may move into endemic stage in 2022, says Moderna co-founder - Mint", "description": "Further, he said that Moderna\u2019s omicron-specific booster shot could enter into human trials within weeks", "url": "https://www.livemint.com/news/world/covid19-pandemic-may-move-into-endemic-stage-in-2022-says-moderna-cofounder-11642170789461.html", "urlToImage": "https://images.livemint.com/img/2022/01/14/600x338/covid_tests_1642171055211_1642171055335.jpg", "publishedAt": "2022-01-14T14:40:12Z", "content": "The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the omicron variant spreads, according to Moderna Inc. co-founder Noubar Afeyan.\r\nWhile s\u2026 [+1693 chars]"}]}, "2022-01-13": {"status": "ok", "totalResults": 5, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna", "description": "It's not even close.", "url": "https://www.fool.com/investing/2022/01/13/5-reasons-pfizer-better-stock-to-buy-than-moderna/", "urlToImage": "https://g.foolcdn.com/editorial/images/660481/vaccine-shot-globe-currency-symbols-and-charts.jpg", "publishedAt": "2022-01-13T10:52:00Z", "content": "Some investors could look at the relative momentum to pick between two stocks. For example, Pfizer(NYSE:PFE) has been a much bigger winner than\u00a0Moderna(NASDAQ:MRNA) over the past several months.\u00a0\r\nOt\u2026 [+4029 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Jack Denton", "title": "Stock Market Today: Dow Rises, Moderna Falls, Coinbase Climbs - Barron's", "description": "<ol><li>Stock Market Today: Dow Rises, Moderna Falls, Coinbase Climbs\u00a0\u00a0Barron's\r\n</li><li>Wall Street rises as inflation data backs Fed bets\u00a0\u00a0Reuters\r\n</li><li>What to watch today: Wall Street looks a bit higher after Nasdaq's 3-day winning streak\u00a0\u00a0CNBC\r\n</li\u2026", "url": "https://www.barrons.com/articles/stock-market-today-51642069887", "urlToImage": "https://images.barrons.com/im-435154/social", "publishedAt": "2022-01-13T14:46:00Z", "content": "Stocks were inching higher as producer prices rose at a slower-than-expected pace in December.\r\nShortly after the open, the Dow Jones Industrial Average was up 102 points, or 0.3%, while the S&amp;P \u2026 [+147 chars]"}, {"source": {"id": null, "name": "Livemint"}, "author": "WSJ", "title": "Moderna expects to report vaccine data for young children in March", "description": "If the data are supportive and, subject to regulatory consultation, Moderna may proceed with regulatory filings", "url": "https://www.livemint.com/companies/news/moderna-expects-to-report-vaccine-data-for-young-children-in-march-11642081094461.html", "urlToImage": "https://images.livemint.com/img/2022/01/13/600x338/moderna_1642081248006_1642081248114.JPG", "publishedAt": "2022-01-13T13:41:37Z", "content": "Moderna Inc. on Wednesday said it expects to report data from its Covid-19 vaccine trial in children ages 2 to 5 in March.\r\nIf the data are supportive and, subject to regulatory consultation, Moderna\u2026 [+542 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Moderna vaccine to be used as booster doses in place of Pfizer", "description": "The Directorate General of Health Services, or DGHS, has ordered Moderna COVID-19 vaccines to be used in place of Pfizer shots for booster doses at vaccination centres across the country.", "url": "https://bdnews24.com/health/2022/01/13/moderna-vaccine-to-be-used-as-booster-doses-in-place-of-pfizer", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/07/14/moderna-vaccine-140721-02.jpg/ALTERNATES/w640/moderna-vaccine-140721-02.jpg", "publishedAt": "2022-01-13T04:34:01Z", "content": "The Pfizer vaccine will, instead, be reserved for use as the first and second doses for students in school and college (ages 12-17) and other people who have already received one dose of the Pfizer v\u2026 [+1242 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Peter Schacknow", "title": "Stocks making the biggest moves premarket: Delta Air Lines, Moderna, Virgin Orbit and others", "description": "These are the stocks posting the largest moves before the bell.", "url": "https://www.cnbc.com/2022/01/13/stocks-making-the-biggest-moves-premarket-delta-air-lines-moderna-virgin-orbit-and-others.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106933521-1629978968043-gettyimages-1336380437-cg6a0877_2021082525657903.jpeg?v=1629979036", "publishedAt": "2022-01-13T12:48:48Z", "content": "Check out the companies making headlines before the bell:\r\nDelta Air Lines (DAL) Delta shares rose 2.2% in the premarket after the airline beat top and bottom-line estimates for the fourth quarter. D\u2026 [+2376 chars]"}]}, "2022-01-12": {"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "Forbes"}, "author": "Mason Bissada, Forbes Staff, \n Mason Bissada, Forbes Staff\n https://www.forbes.com/sites/masonbissada/", "title": "Moderna Expects Vaccine Data For Kids Ages 2-5 By March", "description": "The company is also evaluating boosters for 12- to 17-year-olds as Covid-related hospitalizations for children reach record levels.", "url": "https://www.forbes.com/sites/masonbissada/2022/01/12/moderna-expects-vaccine-data-for-kids-ages-2-5-by-march/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61df66f889873ddeb734b4ed%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D3000%26cropY1%3D115%26cropY2%3D1804", "publishedAt": "2022-01-12T23:42:14Z", "content": "Modern announced Wednesday it aims to report data of the efficacy of its Covid-19 vaccine in children ages 2-5 by March, and hopes to evaluate its booster shot for those ages 12-17 as Covid-related h\u2026 [+2994 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Moderna expects COVID-19 vaccine trial data for children aged 2 to 5 in March", "description": "Moderna said on Wednesday (Jan 13) it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March.\r\n\r\n\"If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for \u2026", "url": "https://www.channelnewsasia.com/world/moderna-covid-19-vaccine-trial-children-march-data-2432026", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--MplHWMBa--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-12t222219z_1_lynxmpei0b116_rtroptp_3_health-coronavirus-moderna.jpg?itok=RoLSQtqm", "publishedAt": "2022-01-12T23:00:34Z", "content": "Moderna said on Wednesday (Jan 13) it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March.\r\n\"If the data is supportive and subject to regulatory cons\u2026 [+598 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Mia Rabson", "title": "Canada has contracts for up to 100 million Pfizer, Moderna doses in 2022 - CP24 Toronto's Breaking News", "description": "Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.", "url": "https://www.cp24.com/news/canada-has-contracts-for-up-to-100-million-pfizer-moderna-doses-in-2022-1.5736632", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5600588.1641961334!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-12T04:22:44Z", "content": "OTTAWA - Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.\r\nBut even as the National Advis\u2026 [+3919 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan Block", "title": "Moderna expects COVID vaccine data in young children in March - Bloomberg", "description": "Moderna said that it plans to report data on its COVID-19 vaccine in children between the ages of 2 and 5 years old in March, Bloomberg reports.", "url": "https://seekingalpha.com/news/3787639-moderna-expects-covid-vaccine-data-in-young-children-in-march-bloomberg", "urlToImage": "https://media.gettyimages.com/photos/general-information-about-moderna-covid19-vaccine-by-cdc-on-flag-of-picture-id1298360732?b=1&k=20&m=1298360732&s=170667a&w=0&h=X-yI4UgenC051XYMbRpHFGxxSy3fBI8xAbpNH8o5Z7A=", "publishedAt": "2022-01-12T20:25:24Z", "content": "Evgenia Parajanian/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "medRXiv", "title": "Effectiveness of mRNA-1273 (Moderna) against SARS-CoV-2 omicron and delta variants (ineffective against Omicron unless boosted)", "description": "Background The recently emerged SARS-CoV-2 omicron variant raised concerns around potential escape from vaccine-elicited immunity....Here, we report VE of 2 or 3 mRNA-1273 doses against infection and hospitalization with omicron and delta, including among imm\u2026", "url": "https://freerepublic.com/focus/f-chat/4028802/posts", "urlToImage": null, "publishedAt": "2022-01-12T12:56:50Z", "content": "Skip to comments.\r\nEffectiveness of mRNA-1273 (Moderna) against SARS-CoV-2 omicron and delta variants (ineffective against Omicron unless boosted)medRXiv ^\r\n | January 8, 2022\r\n | Hung Fu Tseng, Brad\u2026 [+4667 chars]"}, {"source": {"id": null, "name": "National Observer"}, "author": "Mia Rabson", "title": "Canada stocking up on Pfizer, Moderna doses for 2022", "description": "Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.", "url": "https://www.nationalobserver.com/2022/01/12/news/canada-stocking-pfizer-moderna-doses-2022", "urlToImage": "https://www.nationalobserver.com/sites/nationalobserver.com/files/img/2022/01/12/20220111150152-61ddee044cb2675aaecf2239jpeg.jpg", "publishedAt": "2022-01-12T13:43:59Z", "content": "Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.\r\nBut even as the National Advisory Commi\u2026 [+4154 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March", "description": "Moderna Inc <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> said on Wednesday it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-expects-covid-19-vaccine-trial-data-children-aged-2-5-march-2022-01-12/", "urlToImage": "https://www.reuters.com/resizer/eq-mcizr9AaRkiseUM_jAzUT-Eg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/MUL5BDPA7BI5XH4USOGMA5G7QY.jpg", "publishedAt": "2022-01-12T22:22:46Z", "content": "A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike SegarJan 12 (Reuters) - Moderna Inc (MRNA.O) said on \u2026 [+954 chars]"}]}, "2022-01-11": {"status": "ok", "totalResults": 10, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Moderna Stock Is Slipping Today", "description": "Some investors appear to be taking advantage of yesterday's gains.", "url": "https://www.fool.com/investing/2022/01/11/why-moderna-stock-is-slipping-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/660842/scientists-holding-vaccine-bottle.jpg", "publishedAt": "2022-01-11T16:18:00Z", "content": "What happened\r\nShares of Moderna(NASDAQ:MRNA) were sliding 5.1% lower as of 11 a.m. ET on Tuesday. The decline appears to be the result of some profit-taking after Moderna's shares jumped on Monday a\u2026 [+1380 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Vladimir Zernov", "title": "Why Moderna Stock Is Down By 5% Today", "description": "The stock made an attempt to settle below $221.", "url": "https://finance.yahoo.com/news/why-moderna-stock-down-5-163935778.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/GmGrhBTC2K8znpWoJufp5w--~B/aD00MTA7dz02MTU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fx_empire_176/b7f02feb102478d827b7e75ae67effed", "publishedAt": "2022-01-11T16:39:35Z", "content": "Improved Guidance Failed To Provide Sustainable Support To Moderna Stock\r\nShares of Moderna\u00a0gained downside momentum today as traders took some profits off the table after yesterdays rally.\r\nModerna \u2026 [+1923 chars]"}, {"source": {"id": null, "name": "Celebitchy.com"}, "author": "Kaiser", "title": "Moderna & Pfizer will have Omicron-targeted boosters available this year", "description": "Embed from Getty Images A few days ago, Moderna CEO Stephane Bancel explained how the company was preparing to develop and provide a second Covid booster shot \u2013 and a fourth shot overall \u2013 to come out this fall. As in, when people are getting their annual flu\u2026", "url": "https://www.celebitchy.com/749010/moderna_pfizer_will_have_omicron-targeted_boosters_available_this_year/", "urlToImage": null, "publishedAt": "2022-01-11T14:40:07Z", "content": "Embed from Getty Images\r\nA few days ago, Moderna CEO Stephane Bancel explained how the company was preparing to develop and provide a second Covid booster shot \u2013 and a fourth shot overall \u2013 to come o\u2026 [+3109 chars]"}, {"source": {"id": "fox-news", "name": "Fox News"}, "author": "Julia Musto", "title": "As omicron surges, CDC shortens Moderna booster waiting period to 5 months", "description": "As more Americans get booster doses of COVID-19 vaccines amidst a surge of the omicron variant, the Centers for Disease Control and Prevention (CDC) said it would make a change to its Moderna booster recommendation.", "url": "https://www.foxnews.com/health/omicron-cdc-recommends-moderna-booster-five-months", "urlToImage": "https://static.foxnews.com/foxnews.com/content/uploads/2022/01/Moderna-Vial.jpg", "publishedAt": "2022-01-11T19:38:29Z", "content": "As more Americans get booster doses of COVID-19vaccines amidst a surge of the omicron variant, the Centers for Disease Control and Prevention (CDC) said it would make a change to its Moderna booster \u2026 [+2052 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer, Moderna focus on fall 2022 vaccine plans - Yahoo Finance", "description": "Pfizer, Moderna focus on fall 2022 vaccine plansYahoo Finance Pfizer CEO: New COVID-19 vaccine that covers Omicron 'will be ready in March'Yahoo Finance Pfizer says Omicron-specific vaccine to be ready by MarchFox Business Pfizer CEO says omicron vaccine will\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157444353", "urlToImage": null, "publishedAt": "2022-01-11T00:33:41Z", "content": "\"It's a dog-eat-dog world out there, and I'm wearing Milkbone underware.\"\r\n-- Norm, from _Cheers_"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "The CDC shortens Moderna booster waiting period - CNET", "description": "Now people who got Moderna's (or Pfizer's) COVID-19 vaccine can get a booster shot five months after their second dose, instead of six.", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157507565", "urlToImage": null, "publishedAt": "2022-01-11T22:12:54Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna booster: Four 'most commonly reported' side effects after third dose - FDA update - Daily Express", "description": "Moderna booster: Four 'most commonly reported' side effects after third dose - FDA updateDaily Express How Long Does Immunity From COVID Booster Shot Last?CBS New York Pfizer COVID vaccine 91% effective against inflammatory syndromeCIDRAP What you need to kno\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157497527", "urlToImage": null, "publishedAt": "2022-01-11T18:13:42Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": "the-washington-post", "name": "The Washington Post"}, "author": "Rachel Pannett", "title": "Moderna vaccines the best \u2014 and Sinovac least effective \u2014 at stopping covid deaths, Singapore data suggests", "description": "Sinovac, an inactivated-virus vaccine not made with messenger RNA technology, is in widespread use in China and the developing world.", "url": "https://www.washingtonpost.com/world/2022/01/11/singapore-coronavirus-vaccine-moderna-sinovac-pfizer/", "urlToImage": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/NPPRGADR3UI6ZITNDQQ4C2Y4SM.jpg&w=1440", "publishedAt": "2022-01-11T09:13:57Z", "content": "In terms of deaths per 100,000 people, there were 11 for those immunized with Sinovac and 7.8 for the Sinopharm vaccine, the state-affiliated Straits Times newspaper reported. The rate dropped for pe\u2026 [+2148 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": "Low De Wei", "title": "Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate", "description": "While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac\u2019s and Sinopharm Group\u2019s shots, which have been widely used in the developing world.", "url": "https://www.japantimes.co.jp/news/2022/01/11/world/science-health-world/singapore-covid-deaths-vaccines-moderna-lowest/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2022/01/np_file_134581-870x489.jpeg", "publishedAt": "2022-01-11T04:25:12Z", "content": "Singapore saw the fewest deaths among those administered a Moderna Inc. shot and the most among those who received Sinovac Biotech Ltd.s vaccine, with the city-states highly inoculated population pro\u2026 [+2049 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Rendall", "title": "The CDC shortens Moderna booster waiting period", "description": "Now people who got Moderna's (or Pfizer's) COVID-19 vaccine can get a booster shot five months after their second dose, instead of six.", "url": "https://www.cnet.com/health/medical/the-cdc-shortens-moderna-booster-waiting-period/", "urlToImage": "https://www.cnet.com/a/img/-XyFIUL3m_wA29n9coIczEJ5kAU=/1200x630/2021/11/24/7fe39916-9ca3-48f8-9ec2-f88b9471e0a6/covid-19-masks-booster-shots-vaccines-syringes-bandaids-winter-2021-cnet-066.jpg", "publishedAt": "2022-01-11T20:50:00Z", "content": "Sarah Tew/CNET\r\nThe US Centers for Disease Control and Prevention on Friday\u00a0adjusted its recommendation\u00a0for people who got Moderna's COVID-19 vaccine, saying they can get a booster five months after \u2026 [+2337 chars]"}]}, "2022-01-10": {"status": "ok", "totalResults": 32, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Joe Tenebruso)", "title": "Why Moderna Stock Jumped Today", "description": "New booster shots could help fund the pharmaceutical giant's promising research program.", "url": "https://www.fool.com/investing/2022/01/10/why-moderna-stock-jumped-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/660728/medical-researchers-gettyimages-1213006106.jpg", "publishedAt": "2022-01-10T20:48:37Z", "content": "What happened\r\nShares of\u00a0Moderna\u00a0(NASDAQ:MRNA) climbed on Monday after the biotechnology leader said it could have a COVID-19 booster vaccine that specifically targets the omicron variant ready by th\u2026 [+1642 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Robert Langreth", "title": "Moderna Says It Has $18.5 Billion in Vaccine Orders for 2022", "description": "Moderna Inc. said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.", "url": "https://www.bloomberg.com/news/articles/2022-01-10/moderna-says-it-has-18-5-billion-in-vaccine-orders-for-2022", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iLgSZOy2_2Ro/v0/1200x800.jpg", "publishedAt": "2022-01-10T12:53:26Z", "content": "Moderna Inc. said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.\r\nIn a \r\nstatement on Monday, the c\u2026 [+858 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Connor Perrett)", "title": "Moderna is working on a booster for the fall that will target the Omicron variant, CEO St\u00e9phane Bancel says", "description": "The latest estimates from the CDC say the Omicron variant accounts for about 95% of all current COVID-19 cases in the US.", "url": "https://www.businessinsider.com/moderna-working-on-covid-19-booster-omicron-variant-ceo-says-2022-1", "urlToImage": "https://i.insider.com/61dc55674129ea0019f34bc1?width=1200&format=jpeg", "publishedAt": "2022-01-10T16:53:07Z", "content": "Moderna CEO St\u00e9phane Bancel on Monday said the company is working to develop a booster shot for its coronavirus vaccine that would work against the Omicron variant of the infectious disease.\u00a0\r\nThe bo\u2026 [+2129 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "ACCESSWIRE", "title": "Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update - Yahoo Finance", "description": "807 million doses of Moderna's COVID-19 vaccine shipped globally in 2021; approximately 25% of those doses shipped to low- and middle-income countriesProduct...", "url": "https://finance.yahoo.com/news/moderna-announces-advances-across-industry-120000330.html", "urlToImage": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png", "publishedAt": "2022-01-10T12:00:00Z", "content": "807 million doses of Moderna's COVID-19 vaccine shipped globally in 2021; approximately 25% of those doses shipped to low- and middle-income countries\r\nProduct sales for 2021 approximately $17.5 bill\u2026 [+22082 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "SA Transcripts", "title": "Moderna, Inc. (MRNA) CEO Stephane Bancel on JPMorgan 40th Annual Healthcare Conference (Transcript)", "description": "Moderna, Inc. (NASDAQ:MRNA) JPMorgan 40th Annual Healthcare Conference Call January 10, 2022 8:15 AM ETCompany ParticipantsStephane Bancel - Chief Executive OfficerConference Call...", "url": "https://seekingalpha.com/article/4478838-moderna-inc-mrna-ceo-stephane-bancel-on-jpmorgan-40th-annual-healthcare-conference-transcript", "urlToImage": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png", "publishedAt": "2022-01-10T19:04:01Z", "content": "Moderna, Inc. (NASDAQ:MRNA) JPMorgan 40th Annual Healthcare Conference Call January 10, 2022 8:15 AM ET\r\n\nCompany Participants\r\n\nStephane Bancel - Chief Executive Officer\r\n\nConference Call Participan\u2026 [+38203 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Anjalee Khemlani", "title": "Pfizer, Moderna focus on fall 2022 vaccine plans", "description": "Pfizer and Moderna are in the market lead for their mRNA vaccines for COVID-19. And with the pandemic raging on, demand only continues to grow.", "url": "https://finance.yahoo.com/news/pfizer-moderna-focus-on-fall-2022-vaccine-plans-220304748.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/.AIzthWhLWtrf3qnbJddKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2022-01/766add20-6fc8-11ec-a7fb-a1b5a1fc06d1", "publishedAt": "2022-01-10T22:03:04Z", "content": "Whether or not people will need to be perpetually boosting against the coronavirus and its seemingly never-ending stream of variants remains unknown, but vaccine manufacturers are already preparing f\u2026 [+4403 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Moderna improves forecast for 2022 sales from COVID-19 vaccine", "description": "The company also said it was developing a booster vaccine candidate, called mRNA-1273.529, that targets the fast-spreading Omicron variant and expects it to advance into clinical trials in early 2022.", "url": "https://www.moneycontrol.com/news/business/moderna-improves-forecast-for-2022-sales-from-covid-19-vaccine-7920741.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/04/moderna-770x433.jpg", "publishedAt": "2022-01-10T13:33:02Z", "content": "Moderna Inc said on Monday it expected to record sales of about $18.5 billion in 2022 from contracts for its COVID-19 vaccine, and about $3.5 billion from potential additional purchases including boo\u2026 [+631 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "JPM 2022: Moderna finds Carisma's macrophage tech compelling enough for $45M cancer research deal", "description": "Moderna is doling out a little bit of its COVID-19 vaccine cash in a $45 million oncology research deal with Carisma Therapeutics to develop up to a dozen targets.", "url": "https://www.fiercebiotech.com/biotech/moderna-finds-carisma-s-macrophage-tech-compelling-enough-for-45m-cancer-research-deal", "urlToImage": "https://qtxasset.com/fiercebiotech/1641825172/Moderna%20Norwood%20plant.jpg/Moderna%20Norwood%20plant.jpg?VersionId=841tabX9e9Thte3jGtoh3ix92_DRs1_7", "publishedAt": "2022-01-10T14:33:00Z", "content": "Moderna is doling out a little bit of its COVID-19 vaccine cash in a $45 million oncology research deal with Carisma Therapeutics to pick up to a dozen targets for development and commercialization.\r\u2026 [+1889 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology", "description": "Moderna Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a...", "url": "https://finance.yahoo.com/news/moderna-carisma-establish-collaboration-develop-113000712.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/j16.mEJXcfaJ7O5bFIJAAQ--~B/aD0xMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ffc8d7a6f9a8e6fb35c642709403ae67", "publishedAt": "2022-01-10T11:30:00Z", "content": "&lt;span class=\"legendSpanClass\"&gt;Collaboration will combine Carisma's engineered macrophage technology&lt;/span&gt;&lt;span class=\"legendSpanClass\"&gt;with Moderna's mRNA and LNP technologies to g\u2026 [+6802 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Moderna Expects to Have COVID-19 Booster Targeting Omicron by Autumn", "description": "WASHINGTON (Sputnik) \u2013 Moderna is developing an updated booster vaccine against COVID-19 set to be released in autumn and to offer protection against Omicron, CEO Stephane Bancel told CNBC.", "url": "https://sputniknews.com/20220110/moderna-expects-to-have-covid-19-booster-targeting-omicron-by-autumn-1092160501.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1092160501.jpg?10831026851641829669", "publishedAt": "2022-01-10T15:47:17Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+2915 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Anissa Gardizy", "title": "Moderna says Omicron-specific vaccine won\u2019t be ready before fall, data in young kids imminent", "description": "Speaking at the virtual J.P. Morgan Healthcare Conference, Moderna chief executive St\u00e9phane Bancel also said the company is working on an all-in-one annual vaccine for respiratory illnesses.", "url": "https://www.bostonglobe.com/2022/01/10/business/moderna-says-omicron-specific-vaccine-wont-be-ready-before-fall-data-young-kids-imminent/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/e3fDCG_nw9wRbQMmksAJj5FYHfM=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/MURDNUJI5EQZH3IF3YZ6PX7ODA.jpg", "publishedAt": "2022-01-10T17:14:26Z", "content": "As cases of the Omicron variant surge in the US, Moderna chief executive St\u00e9phane Bancel said the company is still working on a potentially new version of its COVID-19 vaccine, which wouldnt be avail\u2026 [+2932 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Robert Langreth", "title": "Moderna says it has $18.5 billion in vaccine orders for 2022", "description": "The company said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.", "url": "https://www.bostonglobe.com/2022/01/10/nation/moderna-says-it-has-185-billion-vaccine-orders-2022/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/GfcwbFAFu-Pt_nPQb5mXReZMCCE=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/ZPLZI4TO7XHRZPHRO4RNQ4TU6Q.jpg", "publishedAt": "2022-01-10T13:18:30Z", "content": "Moderna Inc. said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.\r\nIn a statement on Monday, the com\u2026 [+576 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Moderna improves forecast for 2022 sales from COVID-19 vaccine", "description": ":Moderna Inc said on Monday it expected to record sales of about US$18.5 billion in 2022 from contracts for its COVID-19 vaccine, and about US$3.5 billion from potential additional purchases including booster candidates updated for variants.The company in Nov\u2026", "url": "https://www.channelnewsasia.com/business/moderna-improves-forecast-2022-sales-covid-19-vaccine-2426071", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--CcVJ104j--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-10t124020z_1_lynxmpei090fu_rtroptp_3_health-coronavirus-moderna-fda.jpg?itok=bRefdLfr", "publishedAt": "2022-01-10T12:44:29Z", "content": ":Moderna Inc said on Monday it expected to record sales of about US$18.5 billion in 2022 from contracts for its COVID-19 vaccine, and about US$3.5 billion from potential additional purchases includin\u2026 [+718 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Moderna raises 2022 vaccine sales forecast to US$18.5 billion", "description": "Moderna Inc said on Monday it expected to record sales of about US$18.5 billion in 2022 from contracts for its COVID-19 vaccines, about US$3.5 billion for potential additional purchases including booster candidates updated for variants.The company had forecas\u2026", "url": "https://www.channelnewsasia.com/business/moderna-raises-2022-vaccine-sales-forecast-us185-billion-2426071", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--CcVJ104j--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-10t124020z_1_lynxmpei090fu_rtroptp_3_health-coronavirus-moderna-fda.jpg?itok=bRefdLfr", "publishedAt": "2022-01-10T12:44:29Z", "content": "Moderna Inc said on Monday it expected to record sales of about US$18.5 billion in 2022 from contracts for its COVID-19 vaccines, about US$3.5 billion for potential additional purchases including boo\u2026 [+232 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "4Bio Capital", "title": "4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology", "description": "Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M...", "url": "https://finance.yahoo.com/news/4bio-capital-portfolio-company-carisma-180000031.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/xvVDGejykO5YgPw.Ye5Y1g--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e4a064153272b2dfe2144fb19cb76d3b", "publishedAt": "2022-01-10T18:00:00Z", "content": "Press Release\r\n4BIO CapitalPortfolio Company Carismato Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology\r\nCollaboration will combine Cari\u2026 [+6561 chars]"}, {"source": {"id": null, "name": "New York Daily News"}, "author": "KATE FELDMAN", "title": "Moderna working on COVID-19 booster that targets omicron variant, says CEO", "description": "An omicron-specific booster shot could be ready by the fall, Moderna CEO Stephane Bancel said Monday.", "url": "https://www.nydailynews.com/coronavirus/ny-covid-moderna-booster-vaccine-omicron-20220110-k2kny3yyvnfqpeotkaiwohchdm-story.html", "urlToImage": "https://www.nydailynews.com/resizer/8YdmGl6unstcAi65Ikqu5eeTUxI=/1200x0/top/cloudfront-us-east-1.images.arcpublishing.com/tronc/VUNCNID5MVA4JESRIFZR22WLGM.jpg", "publishedAt": "2022-01-10T15:44:57Z", "content": "An omicron-specific booster shot could be ready by the fall, Moderna CEO Stephane Bancel said Monday.\r\nThe pharmaceutical company is currently working on a targeted shot for the newest COVID-19 varia\u2026 [+1423 chars]"}, {"source": {"id": null, "name": "ValueWalk"}, "author": "Jacob Wolinsky", "title": "Moderna CEO Bancel: Future Covid Vaccine Booster Will Likely Target Omicron Variant", "description": "Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC\u2019s \u201cSquawk Box\u201d (M-F, 6AM-9AM ET) today, Monday, January 10th. Following are links to video on CNBC.com: Q4 2021 hedge fund letters, conferenc\u2026", "url": "https://www.valuewalk.com/moderna-ceo-bancel-future-covid-vaccine-booster-will-likely-target-omicron-variant/", "urlToImage": "https://valuewalk.b-cdn.net/wp-content/uploads/2021/08/Moderna-CEO-Stephane-Bancel.jpg", "publishedAt": "2022-01-10T18:49:54Z", "content": "Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBCs Squawk Box (M-F, 6AM-9AM ET) today, Monday, January 10th. Following are links to\u2026 [+15714 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "Moderna collaborates with Carisma to develop in vivo CAR-M therapeutics for oncology", "description": "Moderna (MRNA) and Carisma Therapeutics have entered into a strategic collaboration agreement to discover, develop and commercialize in vivo engineered chimeric antigen receptor...", "url": "https://seekingalpha.com/news/3786509-moderna-collaborates-with-carisma-to-develop-in-vivo-car-m-therapeutics-for-oncology", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288670274/medium_image_1288670274.jpg", "publishedAt": "2022-01-10T12:03:00Z", "content": "Maddie Meyer/Getty Images News"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Why did Moderna stock go up today? Guidance raise and Omicron booster", "description": "Moderna (MRNA) closed as the best performer in the S&P 500 as investors propelled the beaten-down biotech after the company painted an upbeat outlook for its blockbuster COVID-19...", "url": "https://seekingalpha.com/news/3786880-why-did-moderna-stock-go-up-today-guidance-raise-and-omicron-booster", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288670274/medium_image_1288670274.jpg", "publishedAt": "2022-01-10T21:56:22Z", "content": "Maddie Meyer/Getty Images News"}, {"source": {"id": null, "name": "Toronto Star"}, "author": "Kate Feldman - New York Daily News", "title": "Moderna working on COVID-19 booster that targets Omicron variant, says CEO", "description": "An Omicron-specific booster shot could be ready by the fall, Moderna CEO Stephane Bancel said Monday.", "url": "https://www.thestar.com/news/world/2022/01/10/moderna-working-on-covid-19-booster-that-targets-omicron-variant-says-ceo.html", "urlToImage": "https://images.thestar.com/5MmlWfzrKFiAGy0c54Ku3cqb14E=/1200x800/smart/filters:cb(1641843731468)/https://www.thestar.com/content/dam/thestar/news/world/2022/01/10/moderna-working-on-covid-19-booster-that-targets-omicron-variant-says-ceo/moderna.jpg", "publishedAt": "2022-01-10T19:42:11Z", "content": "An Omicron-specific booster shot could be ready by the fall, Moderna CEO Stephane Bancel said Monday.\r\nThe pharmaceutical company is currently working on a targeted shot for the newest COVID-19 varia\u2026 [+1431 chars]"}]}, "2022-01-09": {"status": "ok", "totalResults": 5, "articles": [{"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "'People are walking away from Moderna': Pharmacists dealing with cancelled booster appointments - CTV News Kitchener", "description": "<ol><li>'People are walking away from Moderna': Pharmacists dealing with cancelled booster appointments\u00a0\u00a0CTV News Kitchener\r\n</li><li>Pharmacists see rise in vaccine shopping\u00a0\u00a0CityNews\r\n</li><li>Booster hesitancy: Why some Quebecers are refusing Moderna\u00a0\u00a0Glob\u2026", "url": "https://kitchener.ctvnews.ca/people-are-walking-away-from-moderna-pharmacists-dealing-with-cancelled-booster-appointments-1.5733045", "urlToImage": "https://www.ctvnews.ca/content/dam/ctvnews/en/images/2021/8/1/moderna-1-5531644-1627871934903.jpg", "publishedAt": "2022-01-09T00:34:00Z", "content": "WATERLOO - \r\nDespite a rush for vaccine booster appointments, some pharmacists say half the people offered the Moderna vaccine have been refusing it.\r\n\"Obviously, that's an empty seat. So the efficie\u2026 [+2655 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-covid-pfizer-moderna-astrazeneca-b1989568.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-09T16:19:56Z", "content": "The more contagious Omicron variant of Covid-19 is continuing to spread rapidly across the UK and could eventually become the dominant strain of the coronavirus.\r\nSo far, more than 75 deaths from the\u2026 [+7421 chars]"}, {"source": {"id": "fox-news", "name": "Fox News"}, "author": "Peter Aitken", "title": "Moderna CEO pushes for second COVID-19 booster shot, but doctors aren't yet convinced it's necessary", "description": "During its third-quarter earnings results report, Moderna said commercial booster market sales could be up to $2 billion in the United States in 2022.", "url": "https://www.foxnews.com/health/moderna-ceo-second-covid-booster-doctors-arent-convinced", "urlToImage": "https://static.foxnews.com/foxnews.com/content/uploads/2022/01/Stephane-Bancel.jpg", "publishedAt": "2022-01-09T20:36:04Z", "content": "Pharmaceutical giant Moderna announced that people may need a second COVID-19vaccine booster shot while health officials continue to explore the need for further shots.\u00a0\r\nModerna CEO Stephane Bancel \u2026 [+4047 chars]"}, {"source": {"id": null, "name": "WJXT News4JAX"}, "author": "Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The U.S. company Moderna has donated 2.7 million doses of coronavirus vaccine to Mexico as the country's official death toll topped 300,000.", "url": "https://www.news4jax.com/health/2022/01/08/moderna-gives-mexico-27-million-shots-as-deaths-top-300000/", "urlToImage": "https://res.cloudinary.com/graham-media-group/image/upload/f_auto/q_auto/c_thumb,w_700/v1/media/gmg/ZCCV66V5FJB7TPXLMR4SIX27HA.jpg?_a=ATABlcW0", "publishedAt": "2022-01-09T00:00:14Z", "content": "MEXICO CITY The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000. \r\nMexico passed 300,000 test-confirmed cor\u2026 [+1070 chars]"}, {"source": {"id": null, "name": "Republic World"}, "author": "Rohit Ranjan", "title": "Mexico receives 2.7 million COVID vaccine doses from Moderna amid Omicron scare", "description": "Moderna, which is a California-based pharmaceutical business, provided Mexico with 2.7 million doses of coronavirus vaccine on Saturday.", "url": "https://www.republicworld.com/world-news/us-news/mexico-receives-2-dot-7-million-covid-vaccine-doses-from-moderna-amid-omicron-scare-articleshow.html", "urlToImage": "https://img.republicworld.com/republic-prod/stories/promolarge/xhdpi/j9otyjc00km5oce0_1641728002.jpeg", "publishedAt": "2022-01-09T11:51:00Z", "content": "Mexico is currently threatened by a massive surge of COVID cases as the death toll surpassed an alarming 300,000 mark. However, the country has got some relief after the\u00a0California-based pharmaceutic\u2026 [+2221 chars]"}]}, "2022-01-08": {"status": "ok", "totalResults": 22, "articles": [{"source": {"id": null, "name": "Blogspot.com"}, "author": "noreply@blogger.com (Unknown)", "title": "MODERNA CEO SAYS PEOPLE MAY NEED ANOTHER BOOSTER IN FALL OF 2022", "description": "<table><tr><td></td></tr><tr><td>A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike Segar</td></tr>\r\n</table>The effectiveness of COVID-19 boosters\u00a0 is likely to wa\u2026", "url": "https://techncruncher.blogspot.com/2022/01/moderna-ceo-says-people-may-need.html", "urlToImage": "https://blogger.googleusercontent.com/img/a/AVvXsEh2b3Jh303RkfbXZtimhEmKXQNOZFkiGaqeFa9iG6NyRDEoLh2HZgF8a5O-3-Mn0da1hkx5srnf4a8GbzxW2c57Nnh11bBI7JY7-XhpyX4VJMvpyWH5HxQU01DUZR2n8FqVBioNranwDMHmPIv_tA_VOtKo3hx2BA0Db57rswoTryEhpBtPuZhH0_spvQ=w1200-h630-p-k-no-nu", "publishedAt": "2022-01-08T16:07:00Z", "content": "The effectiveness of COVID-19 boosters\u00a0 is likely to wane in the coming months, and people may need another shot in the fall of 2022, Moderna Inc CEO St\u00e9phane Bancel told a\u00a0 conference on Thursday on\u2026 [+715 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (David Jagielski)", "title": "1 Big Question Facing Moderna in 2022", "description": "This question could make or break the stock in the years ahead.", "url": "https://www.fool.com/investing/2022/01/08/1-big-question-facing-moderna-in-2022/", "urlToImage": "https://g.foolcdn.com/editorial/images/660156/a-person-receiving-a-vaccine-from-a-nurse_hBHHK3b.jpg", "publishedAt": "2022-01-08T15:30:00Z", "content": "Moderna\u00a0(NASDAQ:MRNA) has gone from a relatively unknown stock a few years ago to a business that's worth more than $85 billion thanks to its COVID-19 vaccine. Many investors have earned great return\u2026 [+3158 chars]"}, {"source": {"id": null, "name": "WBRZ"}, "author": "", "title": "CDC shortens Moderna booster dose interval to 5 months - WBRZ", "description": "<ol><li>CDC shortens Moderna booster dose interval to 5 months\u00a0\u00a0WBRZ\r\n</li><li>COVID vaccine: Does having a high coronavirus antibody level mean you don't need a booster shot?\u00a0\u00a0KABC-TV\r\n</li><li>FDA shortens timing of Moderna booster to 5 months\u00a0\u00a0Santa Rosa P\u2026", "url": "https://www.wbrz.com/news/cdc-shortens-moderna-booster-dose-interval-to-5-months/", "urlToImage": "https://dcer237tfveol.cloudfront.net/v2/WQcLgd5MAJfracIkgkfYpgtYKCqnRi9k_42HSTLXK9AGL2pmnTfr6UN3YwXZgcJ8uPM-0itPplJSEl5pvLCozBBk4vssJSpOOytZTS2lkqvw", "publishedAt": "2022-01-08T20:07:50Z", "content": "BATON ROUGE - The Louisiana Department of Health is following new CDC recommendations to shorten the Moderna booster interval.\r\nThis new guidance calls for the 6-month interval between completing the\u2026 [+778 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Via AP news wire", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The U.S. company Moderna has donated 2.7 million doses of coronavirus vaccine to Mexico as the country's official death toll topped 300,000", "url": "https://www.independent.co.uk/news/mexico-moderna-mexico-city-teachers-chinese-b1989364.html", "urlToImage": "https://static.independent.co.uk/2022/01/04/21/Virus_Outbreak_Mexico_73279.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-08T20:57:19Z", "content": "The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000. \r\nMexico passed 300,000 test-confirmed coronavirus dea\u2026 [+904 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "The Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The US company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the country\u2019s official death toll topped 300,000.", "url": "https://www.bostonglobe.com/2022/01/08/world/moderna-gives-mexico-27-million-shots-deaths-top-300000/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/BXVv8lHJRNv3REm-_QgnLlS7CUw=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/6XXQPKRRBBK7ZNNONASOYTUAMM.jpg", "publishedAt": "2022-01-08T21:09:00Z", "content": "MEXICO CITY (AP) The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000.\r\nMexico passed 300,000 test-confirmed\u2026 [+917 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Alex Lawson", "title": "Moderna working on an annual 'combination' vaccine that could inoculate Brits against Covid and flu", "description": "Moderna is working on a single jab which could inoculate Britons against both Covid and flu as early as next year.", "url": "https://www.dailymail.co.uk/news/article-10382763/Moderna-working-annual-combination-vaccine-inoculate-Brits-against-Covid-flu.html", "urlToImage": "https://i.dailymail.co.uk/1s/2022/01/08/23/52705275-0-image-a-72_1641684449646.jpg", "publishedAt": "2022-01-08T23:28:55Z", "content": "Moderna is working on a single jab which could inoculate Britons against both Covid and flu as early as next year.\r\nThe American drug companys UK chief Darius Hughes said an annual combination vaccin\u2026 [+1918 chars]"}, {"source": {"id": null, "name": "TheGrio"}, "author": "Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the country\u2019s official death toll\nThe post Moderna gives Mexico 2.7 million shots as deaths top 300,000 appeared first on TheGrio.", "url": "http://thegrio.com/2022/01/08/moderna-mexico-vaccine-doses/", "urlToImage": "https://thegrio.com/wp-content/uploads/2022/01/image-7.jpeg", "publishedAt": "2022-01-08T23:26:36Z", "content": "Mexican officials welcomed the arrival of the Moderna shipment at the airport in Toluca, just west of Mexico City\r\nThe U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico \u2026 [+1204 chars]"}, {"source": {"id": null, "name": "TheGrio"}, "author": "Biba Adams", "title": "Fourth vaccine may be needed in the fall, Moderna exec claims", "description": "At a healthcare conference hosted by Goldman Sachs, the CEO of Moderna said front-line workers and people 50 and older\nThe post Fourth vaccine may be needed in the fall, Moderna exec claims appeared first on TheGrio.", "url": "http://thegrio.com/2022/01/07/fourth-vaccine-moderna-fall-2022-claims/", "urlToImage": "https://thegrio.com/wp-content/uploads/2022/01/COVID19BoosterShot.jpg", "publishedAt": "2022-01-08T01:52:13Z", "content": "Boosters given over the past few months will protect those vaccinated through this winter, but their effectiveness could dip by Fall 2022.\r\nAt a healthcare conference hosted by Goldman Sachs, the CEO\u2026 [+2708 chars]"}, {"source": {"id": null, "name": "Tapnewswire.com"}, "author": "Mike Rivero", "title": "Hackers Crack Pfizer, Moderna & Pfizer Servers! All Vaccine Death Data Now Public From All Companies", "description": "GOOD NEWS!!!! Hackers broke into all the pharmaceutical companies and stole all the medial data on vaccines thank God!!!! The Great Awaking has lifted off!!! Forward this link everywhere!!!!\n**Displays number of deaths and disabilities associated with each ba\u2026", "url": "https://tapnewswire.com/2022/01/hackers-crack-pfizer-moderna-pfizer-servers-all-vaccine-death-data-now-public-from-all-companies-thanks-to-hackers/", "urlToImage": null, "publishedAt": "2022-01-08T13:34:01Z", "content": "Fri 10:37 am +00:00, 7 Jan 2022 \u00a03\r\nGOOD NEWS!!!! Hackers broke into all the pharmaceutical companies and stole all the medial data on vaccines thank God!!!! The Great Awaking has lifted off!!! Forwa\u2026 [+2329 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "The Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The U.S. company Moderna has donated 2.7 million doses of coronavirus vaccine to Mexico as the country's official death toll topped 300,000", "url": "https://abcnews.go.com/Health/wireStory/moderna-mexico-27-million-shots-deaths-top-300000-82153914", "urlToImage": "https://s.abcnews.com/images/International/WireAP_fc41b9189e31433980c98d9194697926_16x9_992.jpg", "publishedAt": "2022-01-08T20:57:45Z", "content": "MEXICO CITY -- The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000.\r\nMexico passed 300,000 test-confirmed c\u2026 [+916 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Moderna/Pfizer vaccine \"about 10% effective\" against Omicorn 20 weeks after dose 2. Booster efficacy drops. Likely need a 4th shot.", "description": null, "url": "https://www.investmentwatchblog.com/moderna-pfizer-vaccine-about-10-effective-against-omicorn-20-weeks-after-dose-2-booster-efficacy-drops-likely-need-a-4th-shot/", "urlToImage": null, "publishedAt": "2022-01-08T13:42:52Z", "content": "CNBC article.\r\nI will be surprised when we get that data in the coming weeks that its holding nicely over time I would expect that its not gonna hold great, Bancel said, referring to the strength of \u2026 [+1818 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "townhall.com", "title": "Moderna CEO Says Fourth Vaccine Dose May Be Needed Next Fall", "description": "Moderna CEO Stephane Bancel said Thursday that individuals may need a fourth shot of the Wuhan coronavirus vaccine, CNBC reported. Bancel reportedly made the remarks while speaking with Goldman Sachs at a health care CEO conference. In the discussion, he note\u2026", "url": "https://freerepublic.com/focus/f-news/4027790/posts", "urlToImage": null, "publishedAt": "2022-01-08T16:28:25Z", "content": "Skip to comments.\r\nModerna CEO Says Fourth Vaccine Dose May Be Needed Next Falltownhall.com ^\r\n | 1/7/2022 1715 hrs et\r\n | Madeline Leesman\r\nPosted on 01/08/2022 8:28:25 AM PST by rktman\r\nModerna CEO\u2026 [+4150 chars]"}, {"source": {"id": null, "name": "Toronto Star"}, "author": "The Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "MEXICO CITY (AP) \u2014 The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the country\u2019s official death toll t...", "url": "https://www.thestar.com/news/world/americas/2022/01/08/moderna-gives-mexico-27-million-shots-as-deaths-top-300000.html", "urlToImage": "https://images.thestar.com/-w_eJCnv18wbC0MCxTUEq_PRbFM=/1280x1024/smart/filters:cb(1641675981532)/https://www.thestar.com/content/dam/thestar/news/world/americas/2022/01/08/moderna-gives-mexico-27-million-shots-as-deaths-top-300000/20220104160116-61d4b9fb7d330691d7136c8cjpeg.jpg", "publishedAt": "2022-01-08T20:58:16Z", "content": "MEXICO CITY (AP) The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000. \r\nMexico passed 300,000 test-confirme\u2026 [+921 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Lexi Lonas", "title": "Moderna donates 2.7 million vaccine doses to Mexico as COVID cases surge", "description": "Moderna donated 2.7 million COVID-19 vaccine doses to Mexico as cases surge in the country.\u00a0The donations arrived on Saturday at an airport in Toluca\u00a0after the country this week surp...", "url": "https://thehill.com/policy/international/americas/588891-moderna-donates-27-million-vaccine-doses-to-mexico-as-covid", "urlToImage": "https://thehill.com/sites/default/files/ca_moderna_ap.jpg", "publishedAt": "2022-01-08T23:38:30Z", "content": "Moderna donated 2.7 million COVID-19 vaccine doses to Mexico as cases surge in the country.\u00a0\r\nThe donations arrived on Saturday at an airport in Toluca\u00a0after the country this week surpassed more than\u2026 [+817 chars]"}, {"source": {"id": null, "name": "seattlepi.com"}, "author": null, "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "MEXICO CITY (AP) \u2014 The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the country\u2019s official death toll topped 300,000.\nMexico passed 300,000 test-confirmed coronavirus deaths this week, but so little testing is do\u2026", "url": "https://www.seattlepi.com/news/article/Moderna-gives-Mexico-2-7-million-shots-as-deaths-16759876.php", "urlToImage": "https://s.hdnux.com/photos/01/23/36/54/21883650/3/rawImage.jpg", "publishedAt": "2022-01-08T21:07:41Z", "content": "A woman receives a booster against COVID-19 during a vaccination campaign for people 60 and over, in Mexico City, Tuesday, Jan. 4, 2022.Fernando Llano/AP\r\nMEXICO CITY (AP) The U.S. company Moderna do\u2026 [+1073 chars]"}, {"source": {"id": null, "name": "Www.bna.bh"}, "author": null, "title": "FDA shortens timing of Moderna booster to 5 months", "description": null, "url": "https://www.bna.bh/en/news?cms=q8FmFJgiscL2fwIzON1%2bDs5ghDDoeKuApjuKz4B9N3A%3d", "urlToImage": "https://bna-media.s3-eu-west-1.amazonaws.com/Media/Images/News/World-News/AP21298522191364-e1635189356328-6b9c2815-fe7d-48d3-92b4-bc6cdd11c348.jpeg", "publishedAt": "2022-01-08T10:59:00Z", "content": "Washington, Jan. 8 (BNA): US regulators on Friday shortened the time that people who received Modernas COVID-19 vaccine have to wait for a booster to five months rather than six, the Associated Press\u2026 [+950 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "The FDA just changed the Moderna COVID booster rules - SlashGear", "description": "The FDA just changed the Moderna COVID booster rulesSlashGear Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC saysCNBC Another booster possibleNBC4 Columbus Pfizer/BioNTech vaccine protects children against rare COVID-\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=157273393", "urlToImage": null, "publishedAt": "2022-01-08T16:33:33Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "WSLS 10"}, "author": "Associated Press", "title": "Moderna gives Mexico 2.7 million shots as deaths top 300,000", "description": "The U.S. company Moderna has donated 2.7 million doses of coronavirus vaccine to Mexico as the country's official death toll topped 300,000.", "url": "https://www.wsls.com/health/2022/01/08/moderna-gives-mexico-27-million-shots-as-deaths-top-300000/", "urlToImage": "https://res.cloudinary.com/graham-media-group/image/upload/f_auto/q_auto/c_thumb,w_700/v1/media/gmg/ZCCV66V5FJB7TPXLMR4SIX27HA.jpg?_a=ATABlcW0", "publishedAt": "2022-01-08T22:09:03Z", "content": "MEXICO CITY The U.S. company Moderna donated 2.7 million doses of coronavirus vaccine to Mexico Saturday as the countrys official death toll topped 300,000. \r\nMexico passed 300,000 test-confirmed cor\u2026 [+1070 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": "Tom Yun", "title": "Some are refusing Moderna COVID-19 boosters, pharmacies say", "description": "As Ontario rolls out COVID-19 booster shots, some pharmacies are reporting that people are walking out after being informed that they would be receiving the Moderna vaccine rather than Pfizer's.", "url": "https://www.ctvnews.ca/health/coronavirus/some-ontarians-are-refusing-moderna-boosters-pharmacies-say-1.5732563", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5732564.1641612335!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2022-01-08T03:33:54Z", "content": "TORONTO -- \r\nAs Ontario rolls out COVID-19 booster shots, some pharmacies are reporting that people are walking out after being informed that they would be receiving the Moderna vaccine rather than P\u2026 [+1900 chars]"}, {"source": {"id": null, "name": "WPVI-TV"}, "author": "Luz Pena", "title": "Moderna announces people may need 2nd COVID vaccine booster by fall; here's why multiple doctors disagree", "description": "Moderna announces people may need 2nd COVID vaccine booster by fall; here's why multiple doctors disagree6abc.com", "url": "https://6abc.com/moderna-cdc-booster-second-shot-covid-vaccine/11440020/", "urlToImage": "https://cdn.abcotvs.com/dip/images/11440197_010722-kgo-booster-shot-generic-img.jpg?w=1600", "publishedAt": "2022-01-08T18:53:06Z", "content": "SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach?ABC7 News reporter Luz Pena from San Francisco spoke to multiple Ba\u2026 [+3402 chars]"}]}, "2022-01-07": {"status": "ok", "totalResults": 56, "articles": [{"source": {"id": null, "name": "MarketWatch"}, "author": "Mike Murphy", "title": ": Moderna CEO expects a second COVID booster will be needed later this year", "description": "Moderna Inc.'s CEO expects fully vaccinated people to need an additional COVID-19 booster shot later this year, as the efficacy of the first booster wanes over time.", "url": "https://www.marketwatch.com/story/moderna-ceo-expects-a-second-covid-booster-will-be-needed-later-this-year-11641516954", "urlToImage": "https://images.mktw.net/im-463582/social", "publishedAt": "2022-01-07T00:55:00Z", "content": "Moderna Inc.s CEO expects fully vaccinated people to need an additional COVID-19 booster shot later this year, as the efficacy of the first booster wanes over time.Speaking Thursday at a virtual conf\u2026 [+1806 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino)", "title": "Could Ocugen Become the Next Moderna?", "description": "Ocugen faces a few major challenges.", "url": "https://www.fool.com/investing/2022/01/07/could-ocugen-become-the-next-moderna/", "urlToImage": "https://g.foolcdn.com/editorial/images/660180/gettyimages-1295271909.jpg", "publishedAt": "2022-01-07T11:00:00Z", "content": "Ocugen (NASDAQ:OCGN) became a surprise entrant in the coronavirus vaccine race last year. I say \"surprise\" because the biotech's specialty isn't vaccines or infectious diseases. Its focus is on gene \u2026 [+4137 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Moderna Stock Is Dropping This Week", "description": "Investors seem to be increasingly pessimistic about future demand for Moderna's COVID-19 vaccine.", "url": "https://www.fool.com/investing/2022/01/07/why-moderna-stock-is-dropping-this-week/", "urlToImage": "https://g.foolcdn.com/editorial/images/660283/vaccination-doctor-and-patient.jpg", "publishedAt": "2022-01-07T10:51:00Z", "content": "What happened\r\nShares of Moderna(NASDAQ:MRNA) were dropping 15.2% this week as of market close on Thursday, based on data from S&amp;P\u00a0Global Market Intelligence. The only news from the company in re\u2026 [+1343 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Moderna Stock Was Sluggish on Friday", "description": "The Supreme Court seems to be leaning toward striking down a federal vaccine mandate for large businesses.", "url": "https://www.fool.com/investing/2022/01/07/why-moderna-stock-was-sluggish-on-friday/", "urlToImage": "https://g.foolcdn.com/editorial/images/660434/vaccination-shot-for-woman-in-passenger-seat-of-car.jpg", "publishedAt": "2022-01-07T21:41:00Z", "content": "What happened\r\nA frequent riser because of its status as a top coronavirus stock, Moderna(NASDAQ:MRNA) was falling at roughly a 1% clip in late-afternoon trading Friday. As the company's mRNA-1273 is\u2026 [+1856 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Moderna CEO sees another round of COVID booster jabs in fall", "description": "Omicron may move the world rapidly to an endemic phase, said Moderna chief Stephane Bancel.", "url": "https://www.aljazeera.com/economy/2022/1/7/moderna-ceo-sees-another-round-of-covid-booster-jabs-in-fall", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2022/01/382663573.jpg?resize=1200%2C630", "publishedAt": "2022-01-07T16:23:33Z", "content": "Moderna Inc. Chief Executive Officer Stephane Bancel said another round of vaccine boosters against Covid-19 will probably be needed this fall, even if immunity to the rapidly spreading omicron varia\u2026 [+1887 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Naomi Kresge", "title": "Moderna CEO Sees Another Round of Covid Boosters Needed in Fall", "description": "Moderna Inc. Chief Executive Officer Stephane Bancel said another round of vaccine boosters against Covid-19 will probably be needed this fall, even if the super-infectious omicron variant helps move the planet more quickly into a stage of living with the vir\u2026", "url": "https://www.bloomberg.com/news/articles/2022-01-07/moderna-ceo-sees-another-round-of-covid-boosters-needed-in-fall", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iOeVT6FLXays/v0/1200x800.jpg", "publishedAt": "2022-01-07T11:09:07Z", "content": "Moderna Inc. Chief Executive Officer Stephane Bancel said another round of vaccine boosters against Covid-19 will probably be needed this fall, even if the super-infectious omicron variant helps move\u2026 [+504 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Monica White", "title": "The FDA just changed the Moderna COVID booster rules", "description": "The U.S. Food and Drug Administration (FDA) has announced a change to how long adults must wait before they can get the Moderna COVID-19 vaccine booster shot. Starting immediately, individuals aged 18 and older can now get their booster shot after at least fi\u2026", "url": "https://www.slashgear.com/the-fda-just-changed-the-moderna-covid-booster-rules-07706250/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2022/01/sars-omicron.jpg", "publishedAt": "2022-01-07T19:46:04Z", "content": "The U.S. Food and Drug Administration (FDA) has announced a change to how long adults must wait before they can get the Moderna COVID-19 vaccine booster shot. Starting immediately, individuals aged 1\u2026 [+2560 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Anna Kaplan, Forbes Staff, \n Anna Kaplan, Forbes Staff\n https://www.forbes.com/sites/annakaplan-1/", "title": "FDA Cuts Moderna Booster Waiting Period From Six Months To Five", "description": "The move comes days after the agency also shortened the period between the primary Pfizer series and a booster dose to five months.", "url": "https://www.forbes.com/sites/annakaplan/2022/01/07/fda-cuts-moderna-booster-waiting-period-from-six-months-to-five/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61d8618dd5560c19d4773c29%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D1449%26cropY1%3D150%26cropY2%3D966", "publishedAt": "2022-01-07T16:02:10Z", "content": "Adults who received the Moderna Covid-19 vaccine series now only need to wait five months before receiving a booster dose, the Food and Drug Administration said on Friday, days after the agency short\u2026 [+2445 chars]"}, {"source": {"id": "national-review", "name": "National Review"}, "author": "Zachary Evans, Zachary Evans", "title": "Moderna CEO Says Fourth Covid Vaccine Dose Likely Necessary", "description": "\u2018We have been saying that we believe first this virus is not going away,\u2019 Bancel said.", "url": "https://www.nationalreview.com/news/moderna-ceo-says-fourth-covid-vaccine-dose-may-be-necessary/", "urlToImage": "https://www.nationalreview.com/wp-content/uploads/2022/01/Moderna-Vaccines.jpg?fit=2057%2C1200", "publishedAt": "2022-01-07T13:23:02Z", "content": "Healthcare workers from the El Paso Fire Department prepare Moderna vaccines at a vaccination center near the Santa Fe International Bridge, in El Paso, Texas, May 7, 2021. (Jose Luis Gonzalez/Reuter\u2026 [+2044 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "U.S. FDA cuts gap for Moderna COVID-19 booster dose to five months", "description": "\"Vaccination is our best defense against COVID-19, including the circulating variants, and shortening the length of time between completion of primary series...", "url": "https://news.yahoo.com/u-fda-cuts-gap-moderna-141847144.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/6HtrtvmT6tSwQDH_d.jktQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/6b31717e89e6862f6aee7dcbe1f0436e", "publishedAt": "2022-01-07T14:18:47Z", "content": "(Reuters) - The U.S. Food and Drug Administration said on Friday it shortened the interval between the primary series of the Moderna COVID-19 vaccine and a booster dose by a month for people aged 18 \u2026 [+680 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Fiona Rutherford", "title": "FDA shortens interval for Moderna COVID-19 booster to five months", "description": "US regulators amended the emergency authorization for Moderna Inc.\u2019s COVID-19 vaccine to allow Americans to get a booster shot five months after receiving the initial first two shots.", "url": "https://www.bostonglobe.com/2022/01/07/business/fda-shortens-interval-moderna-covid-19-booster-five-months/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/s_wuPzjTzL_QdfOuCxWr6-Cx7X0=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/KMSFXTGMZ2KVS4YWK62QKRQQJ4.jpg", "publishedAt": "2022-01-07T15:07:46Z", "content": "Peter Marks, director of the FDAs Center for Biologics Evaluation and Research, said in a statement that Fridays action brings consistency in the timing for administration of a booster dose among the\u2026 [+257 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Andrew Jeong", "title": "Fourth vaccine dose could be needed in fall, Moderna CEO says", "description": "People who received booster shots this past fall are likely to have significant protection through winter, St\u00e9phane Bancel, CEO of Cambridge-based Moderna, said at a health care conference Thursday hosted by Goldman Sachs.", "url": "https://www.bostonglobe.com/2022/01/07/business/fourth-vaccine-dose-could-be-needed-fall-moderna-ceo-says/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/d2NsiRySap5p7gEg7CAT0rmgmbk=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/BGHHD3P2BEZWHSA6ITCXMUOQXI.jpg", "publishedAt": "2022-01-07T22:06:38Z", "content": "But he said the efficacy of boosters could dip by next fall: I will be surprised when we get that data in the coming weeks that its holding nicely over time. I would expect that its not going to hold\u2026 [+2739 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "CDC Shortens Wait Time to Receive Booster Shot for Moderna Recipients", "description": "According to the CDC, an initial booster shot from Moderna should be expected to protect individuals through the winter, but by next fall its efficiency could waver, making a fourth shot of the vaccine necessary.", "url": "https://sputniknews.com/20220107/cdc-shortens-wait-time-to-receive-booster-shot-for-moderna-recipients--1092100280.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1092100280.jpg?10906065801641584128", "publishedAt": "2022-01-07T19:35:27Z", "content": "Vaccination is our best defense against COVID-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce wanin\u2026 [+123 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Angus Liu", "title": "CEO pay for Pfizer, J&J, Moderna and AstraZeneca should be tied to COVID-19 vaccine equity, investors say", "description": "COVID-19 vaccine developers have enjoyed a windfall and so have their chief executives. Now, a group of investors are asking the companies to improve vaccine equity by heaping pressure at the C-suite level.", "url": "https://www.fiercepharma.com/pharma/pfizer-j-j-moderna-and-astrazeneca-ceo-pay-packages-should-consider-covid-19-vaccine-equity", "urlToImage": "https://qtxasset.com/fiercepharma/1641571492/Vaccine.jpg/Vaccine.jpg?VersionId=CqSQpyVwPQb2xpZ8FoOpGCyIknXPF0TI", "publishedAt": "2022-01-07T16:05:57Z", "content": "COVID-19 vaccine developers have enjoyed a windfall and so have their chief executives. Now, a group of investors are asking the companies to improve vaccine equity by heaping pressure at the C-suite\u2026 [+3657 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Spencer Kimball", "title": "FDA shortens Moderna booster waiting period to 5 months for adults", "description": "The shortened waiting period for boosters comes as data shows that two doses do not provide strong protection against symptomatic infection from omicron.", "url": "https://www.cnbc.com/2022/01/07/fda-shortens-moderna-booster-waiting-period-to-5-months-for-adults.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106985024-16388120692021-12-06t173003z_1422469075_rc259r9mc2hb_rtrmadp_0_health-coronavirus-usa.jpeg?v=1638812142", "publishedAt": "2022-01-07T21:28:00Z", "content": "The Food and Drug Administration on Friday authorized adults 18 and older who are vaccinated with Moderna to get a booster shot five months after their second dose, shortening the waiting period by a\u2026 [+2363 chars]"}, {"source": {"id": null, "name": "FDA.gov"}, "author": "FDA", "title": "Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months", "description": "The FDA amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.", "url": "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-shortens-interval-booster-dose-moderna-covid-19-vaccine-five-months", "urlToImage": "https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png", "publishedAt": "2022-01-07T13:59:06Z", "content": "For Immediate Release:\r\nJanuary 07, 2022\r\nToday, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the c\u2026 [+1853 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Moderna CEO Bancel says people may need another COVID-19 vaccine booster shot in fall of 2022", "description": "The efficacy of boosters against COVID-19 is likely to decline over the next few months, and people may need another shot in the fall of 2022, Moderna CEO\u00a0Stephane Bancel said at a Goldman Sachs-organised healthcare conference on Thursday (Jan 6).\r\n\r\nBancel s\u2026", "url": "https://www.channelnewsasia.com/world/covid-19-vaccine-booster-moderna-ceo-bancel-says-people-may-need-another-shot-2419916", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--147eprOJ--/c_crop%2Ch_450%2Cw_800%2Cx_0%2Cy_41/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-06t234440z_1_lynxmpei050ym_rtroptp_3_health-coronavirus-puerto-rico.jpg?itok=0cz-75vk", "publishedAt": "2022-01-07T01:16:42Z", "content": "The efficacy of boosters against COVID-19 is likely to decline over the next few months, and people may need another shot in the fall of 2022, Moderna CEO\u00a0Stephane Bancel said at a Goldman Sachs-orga\u2026 [+733 chars]"}, {"source": {"id": null, "name": "Cdc.gov"}, "author": "CDC", "title": "CDC Recommends Moderna Booster at 5 Months", "description": "CDC is\u00a0adjusting\u00a0our recommendation for\u00a0when people can receive a booster shot, shortening the interval from 6 months to 5 months.\u00a0Earlier this week CDC made this recommendation for recipients of a Pfizer-BioNTech primary series and, after FDA action this mor\u2026", "url": "https://www.cdc.gov/media/releases/2022/s0107-moderna-booster.html", "urlToImage": "https://www.cdc.gov/media/dpk/diseases-and-conditions/coronavirus/images/corona-virus-2019-wuhan-600px.jpg", "publishedAt": "2022-01-07T13:25:00Z", "content": "###U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESexternal icon\r\nCDC works 24/7 protecting America\u2019s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chr\u2026 [+214 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Deepa Shivaram", "title": "FDA shortens the wait time between Moderna vaccine and booster to 5 months", "description": "Now, both the Pfizer and the Moderna booster shots can be given five months after the second dose of vaccine \u2014 down from six months.", "url": "https://www.npr.org/sections/coronavirus-live-updates/2022/01/07/1071249854/fda-shortens-the-wait-time-between-moderna-vaccine-and-booster-to-5-months", "urlToImage": "https://media.npr.org/assets/img/2022/01/07/ap22007547106112_wide-14bbb7de7182c5a4ced5377d7d9a1dbfe87fa4a3.jpg?s=1400", "publishedAt": "2022-01-07T16:35:45Z", "content": "A booster dose of the Moderna COVID-19 vaccine is prepared during a vaccination clinic on Dec. 29, in Lawrence, Mass. The FDA is now shortening the wait time between the second dose and the booster t\u2026 [+1559 chars]"}, {"source": {"id": null, "name": "Independent.ie"}, "author": "Gustaf Kilander", "title": "Moderna chief predicts people will likely need a fourth Covid shot", "description": "The CEO of Moderna has said that people will likely need a fourth shot of the vaccine as efficacy and the level of protection wanes over time.", "url": "https://www.independent.ie/irish-news/health/moderna-chief-predicts-people-will-likely-need-a-fourth-covid-shot-41219380.html", "urlToImage": "https://www.independent.ie/irish-news/health/52c3b/41219379.ece/AUTOCROP/w1240h700/Bancel.jpg", "publishedAt": "2022-01-07T18:49:39Z", "content": "The CEO of Moderna has said that people will likely need a fourth shot of the vaccine as efficacy and the level of protection wanes over time.\r\nStephane Bancel, who joined Moderna in 2011, said on Th\u2026 [+3319 chars]"}]}, "2022-01-06": {"status": "ok", "totalResults": 11, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Finding China's Moderna is a financial long shot - Reuters", "description": "Finding China\u2019s answer to Moderna <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> comes with huge health warnings for investors. The $87 billion biotechnology giant\u2019s Covid-19 vaccines have inspired copycats in the People\u2019s Rep\u2026", "url": "https://www.reuters.com/breakingviews/finding-chinas-moderna-is-financial-long-shot-2022-01-06/", "urlToImage": "https://www.reuters.com/resizer/wOeJj8AMbTiNqjB_x_6nK9A3K_M=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/BKAQIG3XGVN7JP2HAKKDHPIJXM.jpg", "publishedAt": "2022-01-06T03:47:00Z", "content": "HONG KONG, Jan 6 (Reuters Breakingviews) - Finding Chinas answer to Moderna (MRNA.O) comes with huge health warnings for investors. The $87 billion biotechnology giants Covid-19 vaccines have inspire\u2026 [+4289 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna CEO Bancel says people may need another booster in fall of 2022 - Reuters", "description": "The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> Chief Executive Officer S\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-ceo-bancel-says-people-may-need-another-booster-fall-2022-2022-01-06/", "urlToImage": "https://www.reuters.com/resizer/Rzq3mg2kaJqCVLO2QMEjj5pNooo=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/3MU3G4X6RVNAPFLOYOQNHCQ2LU.jpg", "publishedAt": "2022-01-06T23:47:00Z", "content": "Jan 6 (Reuters) - The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc (MRNA.O) Chief Executive Of\u2026 [+923 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Andrew Mark Miller", "title": "Moderna CEO says fourth COVID-19 shot could be necessary - Fox Business", "description": "The CEO of Moderna says that a fourth coronavirus vaccine shot may soon be necessary due to declining efficacy of booster shots.", "url": "https://www.foxbusiness.com/politics/moderna-ceo-says-fourth-covid-19-shot-neccessary", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/0/0/pfizer-vaccine.gif?ve=1&tl=1", "publishedAt": "2022-01-06T22:43:44Z", "content": "The CEO of Moderna says that a fourth coronavirus vaccine shot may soon be necessary due to declining efficacy of booster shots.\r\n\"I will be surprised when we get that data in the coming weeks that i\u2026 [+2007 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Moderna CEO Bancel says people may need another booster in fall of 2022", "description": "Bancel said the company is working on a vaccine candidate tailored to the Omicron variant of the coronavirus, but is unlikely to be available in the next two...", "url": "https://news.yahoo.com/moderna-ceo-bancel-says-people-234440558.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/h4MXN5h_PR0F4Z_i14aHnQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/390b9fccf00a6201086a8672bc6ac292", "publishedAt": "2022-01-06T23:44:40Z", "content": "(Reuters) - The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc Chief Executive Officer Stephane \u2026 [+801 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Online Reporters", "title": "3.7m Moderna doses arriving this month", "description": "ZP Therapeutics, a division of Zuellig Pharmwill, will deliver 3.7 million doses of the Moderna Covid-19 vaccine to the Government Pharmaceutical Organization (GPO) and private hospitals this month, the company's general manager in Thailand said on Thursday.", "url": "https://www.bangkokpost.com/thailand/general/2243103/3-7m-moderna-doses-arriving-this-month", "urlToImage": "https://static.bangkokpost.com/media/content/20220106/c1_2243103_700.jpg", "publishedAt": "2022-01-06T07:30:00Z", "content": "ZP Therapeutics, a division of Zuellig Pharmwill, will deliver 3.7 million doses of the Moderna Covid-19 vaccine to the Government Pharmaceutical Organization (GPO) and private hospitals this month, \u2026 [+802 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": null, "title": "Moderna Is Growing With The Vaccine Income", "description": "Moderna is best known for commercializing one of the most successful COVID-19 vaccines. Read more to know why I'm Bullish on MRNA.", "url": "https://seekingalpha.com/article/4478154-moderna-mrna-stock-growing-with-the-vaccine-income", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303673688/medium_image_1303673688.jpg", "publishedAt": "2022-01-06T06:18:52Z", "content": "To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser.\r\nIf you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker\u2026 [+12 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Cristina Laila", "title": "\u2018We\u2019re Gonna Need a Booster in the Fall of \u201922 and Forward\u2019 \u2013 Moderna CEO Pushes Fourth Covid Jab", "description": "Moderna CEO Stephane Bancel on Thursday said people will likely need a Covid booster by the fall of 2022 to increase their protection against the China virus. Bancel said the efficacy of the current booster shot will decline over the next several months and p\u2026", "url": "https://www.thegatewaypundit.com/2022/01/gonna-need-booster-fall-22-forward-moderna-ceo-pushes-fourth-covid-jab/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/moderna-vaccine-shot-vax.jpg", "publishedAt": "2022-01-06T23:10:05Z", "content": "Moderna CEO Stephane Bancel on Thursday said people will likely need a Covid booster by the fall of 2022 to increase their protection against the China virus.\r\nBancel said the efficacy of the current\u2026 [+1557 chars]"}, {"source": {"id": null, "name": "Harvard School of Engineering and Applied Sciences"}, "author": "Jorge Contreras", "title": "Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?", "description": "The NIH, which funded much of Moderna\u2019s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.\nThe post Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna? appeared first o\u2026", "url": "http://blog.petrieflom.law.harvard.edu/2022/01/06/nih-moderna-mrna-covid-vaccine-patent/", "urlToImage": "https://i1.wp.com/blog.petrieflom.law.harvard.edu/wp-content/uploads/2021/10/shutterstock_1437442616-scaled-e1634225948956.jpg?fit=1200%2C800&ssl=1", "publishedAt": "2022-01-06T15:43:02Z", "content": "By Jorge L. Contreras\r\nThe National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Modernas flagship mRNA COVID-19 vaccine (mRNA-1273).\r\nThe NIH\u2026 [+6681 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Spencer Kimball", "title": "Moderna CEO says people may need fourth Covid shot as efficacy of boosters likely to decline over time", "description": null, "url": "https://www.cnbc.com/2022/01/06/moderna-ceo-says-people-may-need-fourth-covid-shot-as-efficacy-of-boosters-likely-to-decline-over-time.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106939460-16312083562021-09-09t172154z_481912034_rc2hmp9eca80_rtrmadp_0_health-coronavirus-spain.jpeg?v=1631208429", "publishedAt": "2022-01-06T21:49:49Z", "content": "Moderna CEO Stephane Bancel on Thursday said the efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot in the fall of 2022 to increase their protectio\u2026 [+3481 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Bangkok Post Public Company Limited", "title": "3.7m Moderna doses arriving this month", "description": "Some 3.7 million doses of the Moderna Covid-19 vaccine will be delivered to the Government Pharmaceutical Organization (GPO) and private hospitals this month.", "url": "https://www.bangkokpost.com/learning/easy/2243143/3-7m-moderna-doses-arriving-this-month", "urlToImage": "https://static.bangkokpost.com/media/content/20220106/c1_2243143_220106162407_700.jpg", "publishedAt": "2022-01-06T09:22:00Z", "content": "Some 3.7 million doses of the Moderna Covid-19 vaccine will be delivered to the Government Pharmaceutical Organization (GPO) and private hospitals this month.\r\nZP Therapeutics, a part of Zuellig Phar\u2026 [+677 chars]"}, {"source": {"id": null, "name": "Global News"}, "author": "Rebecca Lau", "title": "COVID-19: N.B. reports death of person in 30s, only Moderna boosters now being offered - New Brunswick | Globalnews.ca", "description": "New Brunswick is also reporting 672 new cases of COVID-19, along with four new hospitalizations, bringing the total for the province up to 63.", "url": "https://globalnews.ca/news/8493189/nb-covid-19-update-jan-6-2022/", "urlToImage": "https://globalnews.ca/wp-content/uploads/2021/06/CP124714068-1-e1624156636386.jpg?quality=85&strip=all&w=720&h=379&crop=1", "publishedAt": "2022-01-06T19:34:30Z", "content": "New Brunswick is reporting 672 PCR lab-confirmed new COVID-19 cases on Thursday, and the death of a person in their 30s in the Fredericton region.\r\nThere were also 227 recoveries, bringing the active\u2026 [+3250 chars]"}]}, "2022-01-05": {"status": "ok", "totalResults": 3, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adam Spatacco)", "title": "Is Now a Good Time to Buy Moderna Stock?", "description": "After dropping from record highs in August 2021, now may be a good time to assess Moderna's long-term value.", "url": "https://www.fool.com/investing/2022/01/05/is-now-a-good-time-to-buy-moderna-stock/", "urlToImage": "https://g.foolcdn.com/editorial/images/659719/vaccine-covid-coronavirus-pandemic-health_Xy92RxN.jpg", "publishedAt": "2022-01-05T11:55:00Z", "content": "While COVID-19 invoked economic and social hardships, the pandemic has also helped fuel some of the most impressive technological and scientific developments of our time. In 2020, Moderna(NASDAQ:MRNA\u2026 [+4777 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Jaimy Lee", "title": "Moderna begins Phase 1 study of its Epstein-Barr virus vaccine candidate", "description": "Shares of Moderna Inc. were down 0.5% in premarket trading on Wednesday after the company said it began dosing participants in a Phase 1 clinical trial evaluating the company's experimental Epstein-Barr virus vaccine. The virus causes mononucleosis, also call\u2026", "url": "https://www.marketwatch.com/story/moderna-begins-phase-1-study-of-its-epstein-barr-virus-vaccine-candidate-2022-01-05", "urlToImage": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "publishedAt": "2022-01-05T12:22:06Z", "content": "Read Next\r\nModerna Inc. undefined said in a letter to shareholders disclosed Tuesday, Chief Executive St\u00e9phane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-1\u2026 [+1127 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Moderna hits a six-month low shedding over $15B in value after three-day slide", "description": "Reaching the lowest level since June last year, Moderna (MRNA) is on course to post another multi-day rout after recording losses in back-to-back sessions", "url": "https://seekingalpha.com/news/3785576-moderna-hits-a-six-month-low-shedding-over-15b-in-value-after-three-day-slide", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288670274/medium_image_1288670274.jpg", "publishedAt": "2022-01-05T20:59:51Z", "content": "Maddie Meyer/Getty Images News"}]}}